Skip to main content
eLife logoLink to eLife
. 2023 Jan 31;12:e81723. doi: 10.7554/eLife.81723

Ecdysone acts through cortex glia to regulate sleep in Drosophila

Yongjun Li 1,2, Paula Haynes 1,3, Shirley L Zhang 1,, Zhifeng Yue 1, Amita Sehgal 1,
Editors: Mani Ramaswami4, K VijayRaghavan5
PMCID: PMC9928426  PMID: 36719183

Abstract

Steroid hormones are attractive candidates for transmitting long-range signals to affect behavior. These lipid-soluble molecules derived from dietary cholesterol easily penetrate the brain and act through nuclear hormone receptors (NHRs) that function as transcription factors. To determine the extent to which NHRs affect sleep:wake cycles, we knocked down each of the 18 highly conserved NHRs found in Drosophila adults and report that the ecdysone receptor (EcR) and its direct downstream NHR Eip75B (E75) act in glia to regulate the rhythm and amount of sleep. Given that ecdysone synthesis genes have little to no expression in the fly brain, ecdysone appears to act as a long-distance signal and our data suggest that it enters the brain more at night. Anti-EcR staining localizes to the cortex glia in the brain and functional screening of glial subtypes revealed that EcR functions in adult cortex glia to affect sleep. Cortex glia are implicated in lipid metabolism, which appears to be relevant for actions of ecdysone as ecdysone treatment mobilizes lipid droplets (LDs), and knockdown of glial EcR results in more LDs. In addition, sleep-promoting effects of exogenous ecdysone are diminished in lsd-2 mutant flies, which are lean and deficient in lipid accumulation. We propose that ecdysone is a systemic secreted factor that modulates sleep by stimulating lipid metabolism in cortex glia.

Research organism: D. melanogaster

Introduction

Sleep is a resting state that alternates with awake and is broadly conserved in animals (Anafi et al., 2018). With recent advances in our understanding of sleep regulation and function, much of it from small animal models, it is becoming increasing apparent that sleep is more than a brain-regulated process that only serves the brain (Borbély et al., 2016; Dubowy and Sehgal, 2017; Harbison et al., 2009; Hobson, 2005; Shaw et al., 2000). Loss of sleep has systemic effects and is associated with molecular changes in the periphery (Anafi et al., 2013; Chua et al., 2015). In addition, some sleep-promoting effects have been mapped to tissues outside the brain, although the nature of the sleep-regulating signals and their mode of transmission to relevant cells in the brain are poorly understood (Borniger and de Lecea, 2021; Ehlen et al., 2017; Toda et al., 2019).

As a major communication system of the body, endocrine signaling is a promising candidate for mediating long-range effects on sleep (Mong et al., 2011; Morgan and Tsai, 2015; Roller, 2021). Glands of the endocrine system make and release chemical messengers called steroid hormones, which circulate in the blood until they reach their target cells and bind to specific steroid nuclear hormone receptors (NHRs) in the cytosol (Bonora and DeFronzo, 2018; Zubeldia-Brenner et al., 2016). Given that circulating steroid hormones are lipophilic and can easily enter the brain, together with the broad expression of NHRs in the central nervous system, it is reasonable to infer that NHR signaling is a significant contributor to brain function (Yang et al., 2007; King-Jones and Thummel, 2005; Kininis and Kraus, 2008). However, the response mediated by the endocrine system is modulatory, in that it is slower and more long term than fast, synaptic neurotransmission (Morgan and Tsai, 2015). Thus, the endocrine system drives responses to environmental cues and innate signals critical for development, growth, and metabolism (Kannangara et al., 2021; Oostra et al., 2014). Sleep is a chronic behavior regulated over a relatively long timeframe (a daily cycle), so one might expect it also to be sensitive to endocrine signaling. Indeed, endocrine dysfunction affects sleep, and conversely, sleep and sleep loss affect hormone production and hormonal function, but the specificity and mechanisms underlying these interactions remain to be elucidated (Aldabal and Bahammam, 2011; Kim et al., 2015; Terán-Pérez et al., 2012).

To explore the impact of endocrine signaling on sleep, we used a Drosophila model and knocked down each of the known Drosophila NHRs in neurons and glia. We found that the ecdysone receptor (EcR) and Eip75B (E75) function in both cell types to modulate sleep but have more potent effects in glia. EcR knockdown in glia significantly decreases sleep and disrupts circadian rhythms, as does the knockdown of the newly identified ecdysone importer (EcI). EcR functions in cortex glia to affect sleep, and it appears to do so by regulating lipid metabolism. Together these studies identify a long-range signal that modulates sleep in adult Drosophila.

Results

Effects of pan-neuronal and pan-glial knockdown of EcR and E75 on sleep

To identify NHRs that affect sleep in adult Drosophila, we conducted a systematic genetic knockdown screen of all known NHRs. To avoid developmental effects, which are prominent for most NHRs, we sought to address their role in sleep by knocking them down specifically at the adult stage (Nicholson et al., 2008). Based upon single-cell RNAseq data showing that nearly half of known NHRs are highly expressed in adult fly brain both neurons and glia, we used pan-neuronal and pan-glial GeneSwitch (GS) drivers induced in adults with RU486 (nSyb-GS and Repo-GS, respectively) to knock down individual NHRs (Davie et al., 2018; Nicholson et al., 2008). All NHRs were targeted either by two separate RNAi lines or UAS-miRNA transgenic fly lines that polycistronically express two independent miRNAs in the same line (Lin et al., 2009). Surprisingly, we found that knockdown of most NHRs in neurons and glial cells reduced adult sleep by varying levels compared with their GS controls and UAS controls, suggesting that the endocrine system in general plays a positive role in sleep regulation (Figure 1B,C). Among them, knockdown of EcR, the receptor of the primary steroid hormone ecdysone, and its direct downstream targeting gene Eip75B (E75) had the greatest effects on total sleep. Because we noticed that Repo-GS control flies have variable daytime sleep and RU486 induction further reduces daytime sleep, we also analyzed all flies’ nighttime sleep, which is quite stable in all conditions. Importantly, EcR and E75 knockdown affect primarily nighttime sleep and phenotypes are stronger when they are knocked down in glia.

Figure 1. A screen of all nuclear hormone receptors (NHRs) in Drosophila identifies sleep-regulating functions of ecdysone receptor (EcR) and its downstream target, NHR E75.

Figure 1.

(A) Flies carrying a pan-neuronal driver nSyb-GS or pan-glial driver Repo-GS were crossed with different UAS lines carrying RNAi constructs against NHRs, and their 5- to 7-day-old F1 female progeny were loaded into DAM monitors to record their activity under 12:12 hr light:dark cycles. GeneSwitch remains inactive during developmental stages and is activated by RU486 in the food in DAM monitors. Behavior data were collected by the DAM system. (B, C) Mean total and nighttime sleep for each group were calculated by Pysolo. Differences between experimental flies and GS and RNAi controls were calculated separately in each independent experiment, and the average values comparing each experimental to its GeneSwitch control (X-axis) and RNAi control (Y-axis) are shown in the plots. The exact numbers of flies used per line are provided in Figure 1—source data 1. While knockdown of most NHRs reduces sleep, effects of EcR RNAi #1, EcR RNAi #2, E75 RNAi #1 predominate, especially in glial knockdown experiments.

Figure 1—source data 1. Detailed sleep phenotypes of nuclear hormone receptor (NHR) RNAi screening lines.

Across multiple experiments, we found that flies with glial knockdown of EcR slept on average ~460 min, much less than those with neuronal knockdown that slept ~707 min. In addition, the total sleep amount of nSyb-GS>EcR RNAi flies was not significantly reduced compared with nSyb-GS control flies, suggesting that glial EcR has a larger role in determining sleep amount (Figure 2A–D). Knockdown of E75 in either neurons or glia led to severe sleep loss, with ~419 and ~461 min of daily sleep, respectively (Figure 2—figure supplement 1A–D). Because ecdysone is the most common steroid hormone in Drosophila, it directly or indirectly affects multiple NHRs (King-Jones and Thummel, 2005). Indeed, we found that knockdown of ecdysone responsive NHRs reduced sleep more than knockdown of non-ecdysone responsive NHRs, and from the screen of neuronal and glial knockdown, top hits were known ecdysone relevant NHRs (Figure 1—source data 1). If we use 200-min sleep loss compared with both control groups as a cutoff, then two out of three top hits with neuronal knockdown and five out of seven top hits with glial knockdown are ecdysone relevant NHRs. Genes showing the most dramatic sleep loss when knocked down in glia were EcR, E75, Ftz-f1, and Hr3, all directly relevant to the ecdysone signaling pathway. The efficacy of our screen was supported by the identification of non-ecdysone responsive NHR Hr51 (unfulfilled) as a hit affecting circadian rhythms. We found that neuronal, but not glial, knockdown of Hr51 (unfulfilled), previously shown to exert circadian effects by acting in central clock neurons (Beuchle et al., 2012), resulted in an arrhythmic phenotype, with no sleep amount change under 12:12 hr light:dark conditions (Figure 2—figure supplement 2A–D).

Figure 2. Baseline sleep phenotypes resulting from pan-neuronal or pan-glial knockdown of ecdysone receptor (EcR).

(A, B) Show representative sleep traces of nSyb-GS>EcR RNAi #1 and Repo-GS>EcR RNAi #1. N = 14–16 per genotype. Data are based on at least three independent experiments. Representative sleep traces are showed because Pysolo we used does not allow combining data from repeated experiments. Total sleep of the nSyb-GS>EcR RNAi #1 and Repo-GS>EcR RNAi #1 flies for three replicates, N = 43–63, one-way analysis of variance (ANOVA) with Tukey post hoc test was used for (C), and Kruskal–Wallis test with Dunn’s multiple comparisons test was used for (D). (E–H) The average sleep bout number and average sleep bout length of the nSyb-GS>EcR RNAi #1 and Repo-GS>EcR RNAi #1 flies for all three replicates. Daytime sleep data are quantified in the left panels, and nighttime sleep is quantified in the right panels of each group. One-way ANOVA analysis with Tukey post hoc test was used for (E, F) and Kruskal–Wallis test with Dunn’s multiple comparisons test was used for (G, H). (I–K) The rhythmicity, period, and relative Fast Fourier Transform (FFT) power analysis of nSyb-GS>EcR RNAi #1 and Repo-GS>EcR RNAi #1 flies and controls assayed for locomotor activity rhythms in constant darkness. (I) shows the percentage rhythmic in each genotype from all three independent replicates. Flies used for analysis in (J, K) are rhythmic flies from (I), and experimental files are compared with their GeneSwitch and RNAi control flies. Bar graphs show mean + standard error of the mean (SEM), and p values for each comparison were calculated using the Kruskal–Wallis test with Dunn’s multiple comparisons test. ns = not significant, p > 0.05, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. See also Figure 2—source data 1.

Figure 2—source data 1. Sleep and circadian phenotypes resulting from pan-neuronal or pan-glial knockdown of ecdysone receptor (EcR).
Figure 2—source data 2. Sleep phenotypes resulting from pan-neuronal or pan-glial knockdown of E75.
Figure 2—source data 3. Sleep phenotypes resulting from pan-neuronal or pan-glial knockdown of Hr51 and sleep phenotypes of adult-specific neuronal and glial knockdown of ecdysone receptor (EcR).
Figure 2—source data 4. Sleep phenotypes resulting from pan-glial knockdown of ecdysone receptor (EcR) by temporal and regional gene expression targeting (TARGET) system and different EcR RNAi lines.
Figure 2—source data 5. Sleep phenotypes resulting from pan-neuronal or pan-glial knockdown of EcI and overexpression of ecdysone receptor (EcR) common isoforms.

Figure 2.

Figure 2—figure supplement 1. Baseline sleep phenotypes resulting from pan-neuronal and pan-glial knockdown of E75, the direct downstream target of ecdysone receptor (EcR).

Figure 2—figure supplement 1.

(A, B) show representative sleep traces of nSyb-GS>E75 RNAi #1 and Repo-GS>E75 RNAi #1. N = 12–16 per genotype per experiment. Experiments were independently repeated at least two times, and one experiment is shown here. (C, D) Total sleep of the nSyb-GS>EcR RNAi #1 and Repo-GS>EcR RNAi #1 flies shown in (A, B), p values for each comparison were calculated by one-way analysis of variance (ANOVA) with the Tukey post hoc test. (E–H) The average sleep bout number and average sleep bout length of the nSyb-GS>E75 RNAi #1 and Repo-GS>E75 RNAi #1 flies. Daytime sleep data are quantified in the left panels, and nighttime sleep is quantified in the right panels of each group. p values for each comparison in (E–H) were calculated by Kruskal–Wallis test with Dunn’s multiple comparisons test. Bar graphs show mean + standard error of the mean (SEM). ns = not significant, p > 0.05, *p < 0.05, ***p < 0.001, ****p < 0.0001. See also Figure 2—source data 2.
Figure 2—figure supplement 2. Adult-specific neuronal and glial knockdown of ecdysone receptor (EcR) reduces sleep.

Figure 2—figure supplement 2.

(A, B) show representative sleep traces of nSyb-GS>Hr51 RNAi and Repo-GS>Hr51 RNAi. N = 26–32 per genotype. Experiments were independently repeated two times, and one experiment is shown here. (C, D) Total sleep of the nSyb-GS>Hr51 RNAi and Repo-GS>Hr51 RNAi flies shown in (A, B), p values for each comparison were calculated by one-way analysis of variance (ANOVA) with the post hoc test. (E, F) show representative sleep traces of nSyb-GS>EcR RNAi #1 and Repo-GS>EcR RNAi #1 female flies with vehicle control or RU486; experiments were independently repeated at least two times. (G, H) Total sleep of the nSyb-GS>EcR RNAi #1 RNAi and Repo-GS>EcR RNAi #1 female flies with vehicle control or RU486, N = 28–40 per genotype. Bar graphs show mean + standard error of the mean (SEM), and ns = not significant, p > 0.05, *p < 0.05, ***p < 0.001, ****p < 0.0001. The comparison was calculated with an unpaired parametric Student’s t-test for Repo-GS groups and Mann–Whitney test for nSyb-GS groups. See also Figure 2—source data 3.
Figure 2—figure supplement 3. Adult-specific knockdown of ecdysone receptor (EcR) by using the temporal and regional gene expression targeting (TARGET) system reduces sleep.

Figure 2—figure supplement 3.

(A) Sleep traces resulting from pan-glial adult-specific EcR knockdown by using Repo-Gal4; TubulinGal80ts crossed with UAS-EcR RNAi #1. Five-day-old F1 progeny flies were maintained at 18 degrees for 1 day, then switched to 31 degrees to inactivate Gal80ts, resulting in EcR knockdown over the next 2 days. Subsequently, the temperature dropped to 18 degrees in the last day. (B) Quantification of total sleep in pan-glial EcR knockdown flies using Repo-Gal4/TubulinGal80ts, N = 38–59 per genotype and experiments were independently repeated at least two times. Total sleep amount was calculated for each genotype and compared to the control group for four different days. p values for each comparison were calculated by one-way analysis of variance (ANOVA) using Tukey’s post hoc test. (C–E) Total sleep quantification of EcR RNAi knockdown using three different EcR RNAi lines BDSC #9328, #9329, and #9452. N = 16–32 per genotype and experiments were independently repeated two times, p values for each comparison were calculated by one-way analysis of variance (ANOVA) with the Tukey post hoc test. Black bars are Repo-GS control flies, gray bars are UAS-RNAi control flies, and green bars are different Repo-GS>EcR RNAi flies, indicated by their titles. Bar graphs show mean + standard error of the mean (SEM), ns = not significant, p > 0.05, *p < 0.05, ***p < 0.001, ****p < 0.0001. See also Figure 2—source data 4.
Figure 2—figure supplement 4. Baseline sleep phenotypes resulting from pan-neuronal and pan-glial overexpression of ecdysone receptor (EcR) common isoforms and knockdown of EcI, the membrane importer of ecdysone.

Figure 2—figure supplement 4.

(A, B) show representative sleep traces of nSyb-GS>EcI RNAi #1 and Repo-GS>EcI RNAi #1 flies, (C, D) Total sleep quantification of the nSyb-GS>EcI RNAi #1 and Repo-GS>EcI RNAi #1 flies and their controls. N = 25–30; data are based on two independent experiments. (E, F) show representative sleep traces of nSyb-GS>EcR_c and Repo-GS>EcR_c flies, N = 35–48 per genotype; data are based on three independent experiments. (G, H) Total sleep of the nSyb-GS>EcR_c and Repo-GS>EcR_c flies. p values for each comparison were calculated by one-way analysis of variance (ANOVA) with Tukey post hoc test. Bar graphs show mean + standard error of the mean (SEM); ns = not significant, p > 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. See also Figure 2—source data 5.

Sleep architecture analysis showed that neuronal or glial-specific knockdown of EcR or E75 reduces sleep amount by fragmenting sleep, with larger effects seen with the glial-specific knockdown (Figure 2E–H, Figure 2—figure supplement 1E–H). Glial EcR and E75 knockdown flies had shorter average sleep bout lengths during the day and night and more sleep bouts at night, indicating that their sleep is fragmented (Figure 2F, H and Figure 2—figure supplement 1F, H). Comparison of RU486-treated flies with vehicle-treated controls confirmed that adult-specific knockdown of EcR is sufficient to reduce sleep in both neuronal and glial populations (Figure 2—figure supplement 2E–H). To confirm effects of adult-specific knockdown, we used the temporal and regional gene expression targeting (TARGET) system in which expression of Repo-Gal4 can be restricted to adults by using a temperature-sensitive allele of a Gal4 suppressor, Gal80 (McGuire et al., 2003). The results show that Repo-Gal4; TubGal80ts>EcR RNAi #1 flies sleep a similar amount at permissive temperature (18 degrees) as control flies, but their sleep is significantly less at restricted temperature (31 degrees), confirming that EcR acts in adult glia to regulate daily sleep (Figure 2—figure supplement 3A,B).

Since EcR RNAi #1 and #2 used in the initial screening are two independent P-element transgenic lines but were generated using the same construct, we also tested three other EcR RNAi lines with Repo-GS, all of which produced reduced sleep phenotypes, further confirming that EcR RNAi knockdown in glial cells reduces sleep (Figure 2—figure supplement 3C–E). Furthermore, we tested the function of the recently identified ecdysone membrane transporter EcI, whose expression is necessary for ecdysone uptake by cells (Okamoto et al., 2018). As with EcR, glial knockdown of EcI reduced overall sleep levels and led to more fragmented sleep (Figure 2—figure supplement 4A–D). In general, all these data strongly indicate that ecdysone signaling acts in the brain, particularly in glia, to modulate sleep.

To assay flies for free-running circadian rhythms, we monitored them under constant darkness (DD) conditions. In DD, half of the nSyb-GS EcR knockdown flies and 90% of Repo-GS EcR knockdown flies became arrhythmic, but the remaining rhythmic flies showed no difference from controls in their period or FFT (Fast Fourier Transform) values that are a measure of rhythm strength (Figure 2I–K). Our finding that EcR functions are required in glia to promote circadian locomotor rhythms and sleep is novel and consistent with previous work showing that E75 or EcR knockdown in central clock cells causes some locomotor arrhythmicity, but more dramatic phenotypes result from knockdown with drivers such as tim27-Gal4 that additionally express in glia (Kumar et al., 2014).

Next, we overexpressed EcR and found that, in contrast to our knockdown experiments, overexpression in neurons and glia had no effect on total sleep, but Repo-GS>EcR_c flies showed a consistent phase shift at dusk (Figure 2—figure supplement 4E–H). Thus, effects of EcR on sleep and rhythms are largely through glia, and not neurons. Regarding the lack of sleep phenotypes from overexpression, it is possible that sleep-relevant ecdysone signaling is saturating in both neurons and glia and increasing EcR does not confer new sleep-promoting functions. However, since exogenous ecdysone feeding promotes sleep (Ishimoto and Kitamoto, 2010), it is also possible that the EcR ligand ecdysone is rate limiting when EcR is overexpressed.

Starvation and glial ecdysone signaling act independently to regulate sleep amount

Sleep changes under stress conditions, and ecdysone is implicated in stress responses (Hill et al., 2018; Ishimoto and Kitamoto, 2011; Williams, 2019), raising the possibility that ecdysone mediates the effects of stressors on sleep. Starvation is an example of a stressor that raises ecdysone levels in female flies (Terashima et al., 2005). Although its effect on sleep goes in the opposite direction, that is, starvation reduces sleep, we asked whether ecdysone is relevant for effects of starvation (Keene et al., 2010) for instance, does downregulation of ecdysone signaling in specific cells (despite overall increased ecdysone) account for decreased sleep during starvation? As shown by Ishimoto and Kitamoto, 2010 , we also found that feeding of the exogenous bioactive form of ecdysone, 20E, promotes sleep in fed wild-type flies (Figure 3 A, E); we then asked if starved flies respond to 20E as well. Exogenous ecdysone abrogated sleep loss caused by starvation, indicating that EcRs are functional in sleep-relevant cells under these conditions (Figure 3B, E). Consistent with this, we found that mRNA levels of ecdysone responsive genes—EcR, EcI, E75, and E74—in the fly brain are not altered after 1 day of starvation (Figure 3—figure supplement 2D). Interestingly, starved flies fed 20E showed rebound sleep when they were returned to food, even though these flies did not lose sleep during starvation, indicating that 20E does not rescue the need for sleep that builds up during starvation (Regalado et al., 2017).

Figure 3. Ecdysone feeding prevents sleep loss in response to starvation, while ecdysone receptor (EcR) KD exacerbates starvation-induced sleep loss.

Sleep was monitored for 3 days either under continuous feeding with and without 0.2 mM ecdysone (A) or under each of the following three conditions—continuous feeding for 3 days or with an intervention on the second day, which consisted of either starvation or starvation accompanied with the feeding of 0.2 mM ecdysone (B). The assay was conducted in (A, B) wild-type flies (wCS) and (C, D) nSyb-GS and Repo-GS EcR RNAi #1 flies. N = 15–32 for each genotype, and the experiment was repeated two times. Quantification of sleep nomalized to vehicle control group for the average daily sleep for (A) and ZT0–ZT23h interval of the second day for (B–D) is shown in (E). ZT0–ZT23 sleep data are shown as flies were flipped back to locomotor tubes with food during the last hour (ZT23–24). Bar graphs show mean ± standard error of the mean (SEM) and ns = not significant, p > 0.05, ***p <0 .001, ****p < 0.0001. p values for comparisons between two groups were based on the Mann–Whitney test, and p values for comparison between three groups were calculated by one-way analysis of variance (ANOVA) with Tukey post hoc test. See also Figure 3—source data 1.

Figure 3—source data 1. Sleep phenotypes of starvation on wild-types and ecdysone receptor (EcR) disrupted flies.
Figure 3—source data 2. Sleep phenotypes of ecdysone treatment and heat shock when ecdysone receptor (EcR) was disrupted in neurons and glial cells.
Figure 3—source data 3. Ecdysone levels in both fly brain and periphery, and the expression levels of ecdysone responsive genes.

Figure 3.

Figure 3—figure supplement 1. Ecdysone receptor (EcR) disruption in neurons or glia does not affect the response to heat shock.

Figure 3—figure supplement 1.

(A) Total sleep of EcR RNAi #1 knockdown flies in both neurons and glia and their genetic control flies after 0.1 mM 20E feeding, N = 29–46, and experiments were repeated two or three times independently. (B) The last 4 hours’ sleep between ZT20 and ZT24 after heat shock for an hour at ZT18 of EcR RNAi #1 knockdown flies in neurons or glia and their genetic control flies, N = 16. Bar graphs show mean + standard error of the mean (SEM); ns = not significant, p > 0.05, *p < 0.05, **p <0 .01, ****p < 0.0001. p values for each comparison were calculated by one-way analysis of variance (ANOVA) with Tukey post hoc test. See also Figure 3—source data 2.
Figure 3—figure supplement 2. Ecdysone levels are higher in the fly periphery at ZT14 compared to ZT2.

Figure 3—figure supplement 2.

(A) Ecdysone level was measured in the fly’s whole body or brain using an ELISA (enzyme-linked immunosorbent assay) kit. 20E levels are higher at ZT14 than ZT2 in the periphery. (B) A and B isoforms of the direct downstream target gene of ecdysone, E75, were measured by qPCR in fly heads or fly bodies at four different time points. Data indicate a significant rhythm with a mid-afternoon–evening peak in heads (JTK values, which are measures of cycling, are below the x-axis). (C) E75 isoform A and B mRNA levels in the fly brain following 20E/Vehicle injection at ZT6 or ZT18. The mRNA levels were measured 1 hr after flies were injected with 20E or vehicle control and changes seen with 20E (relative to vehicle control) in the brain at different time points were normalized to the changes in the body to control for inconsistency of the injection. (D) mRNA levels of EcR, EcI, E75, and E74 in the fly brains do not respond to 1 day of starvation. All comparisons’ p > 0.05 in (C); thus, these are not shown. Bar graphs show mean + standard error of the mean (SEM), and ns = not significant, p > 0.05, *p < 0.05. p values for each comparison are calculated by unpaired parametric Student’s t-test. See also Figure 3—source data 3.

To determine whether increased sleep after 20E feeding is mediated by neurons or glia, we knocked down EcR in each of those two cell types. Sleep increased following 20E administration in nSyb-GS>EcR RNAi flies, but not Repo-GS>EcR RNAi flies (Figure 3—figure supplement 1A). As the Repo-GS control flies also did not respond to 20E feeding, we cannot draw conclusions about the necessity of EcR expression in glia for effects of exogenous ecdysone. However, neuronal ecdysone signaling appears to be dispensable for this purpose.

We next asked how knockdown of EcR in neurons versus glia effects the response to starvation and found that while starvation reduced sleep in flies in which EcR was knocked down in neurons, the effects was not significant (Figure 3C, E). Although this could suggest a role of neuronal ecdysone signaling in the response to starvation, it could also be due to variability in the data. On the other hand, robust sleep loss was seen with starvation when EcR was knockdown in glia even though baseline sleep is already quite low in these flies (Figure 3D, E). Although the percentage of sleep loss was higher in Repo-GS>EcR RNAi flies than in controls (68% vs. 30%), because the baseline was lower, the absolute amount of sleep loss was about the same. These data indicate that starvation and ecdysone signaling in glia independently regulate sleep and a large part of sleep remaining in starved flies derives from ecdysone signaling in glia. We also examined the response to a stressor that increases sleep, heat shock, and found that sleep induced by heat shock was not affected by EcR knockdown in neurons or glia (Figure 3—figure supplement 1B).

Ecdysone cycles in the periphery and has higher action on the brain at night

Given that ecdysone modulates rhythmic behavior, the question arises whether it is under circadian regulation. We used multiple methods, including a genetic reporter (hs-Gal4-EcR.LBD), mass spectrometry, and an ecdysone ELISA (enzyme-linked immunosorbent assay) kit, to determine if 20E cycles in the brain over a day–night cycle (Ishimoto and Kitamoto, 2010). However, ELISA analysis indicated that 20E level is significantly higher at ZT14 than ZT2 in the fly periphery but not in the fly brain (Figure 3—figure supplement 2A). In the fly brain, even genetic reporters and mass spectrometry approaches failed to detect any significant differences in 20E levels. Our inability to detect a cycle in the brain, despite a previously reported peak at ZT12 in the fly head (Ishimoto and Kitamoto, 2010), could reflect the rapid metabolism of 20E following its action on brain tissues. Alternatively, changes of 20E levels in the fly brain may be too small to be detected (Vafopoulou and Steel, 2012). In support of circadian regulation of ecdysone signaling, mRNA levels of ecdysone responsive E75 isoforms cycle with a peak at ZT12 in the fly head, suggesting that ecdysone acts rhythmically in the fly brain (Figure 3—figure supplement 2B), though this rhythmicity could also be contributed by direct clock regulation of E75 as suggested by Abruzzi et al., 2011. Given that E75 isoforms do not peak at ZT12 in the fly periphery, we suggest that elevated ecdysone at this time enters the brain instead of acting on peripheral tissues. To determine whether ecdysone enters the brain more efficiently at night, we examined whether E75 isoforms show differential responses to peripheral injection of 20E at ZT 6 versus ZT18. We normalized the change in E75 expression in the brain to the change in the body to account for inconsistency of injection and found that the mRNA levels of both E75A and E75B increased more at ZT18, compared to ZT6, after 20E injection, E75A increased 1.67-fold at ZT6, and 3.91 at ZT18, while E75B increased 17-fold at ZT6, and 51.92-fold at ZT18 (Figure 3—figure supplement 2C). This result indicates that peripheral ecdysone has higher action in the brain at night.

EcR functions in cortex glia to affect sleep

Given the relevance of glia to EcR effects on sleep, we focused on uncovering its function in glial cells. We first assayed the expression of EcR in adult brains. Consistent with previous reports, antibody staining in the adult fly brain showed that EcR is broadly expressed, but largely in the cortex glia. To confirm the localization to cortex glia, we used two separate cortex glia drivers, GMR77A03-Gal4 and Np2222-Gal4, to drive the expression of mCD8-RFP. Co-staining these brains with an antibody against EcR confirmed that EcR is expressed primarily in the cortex glia (Figure 4A). When EcR was knocked down in glia with Repo-GS, EcR antibody staining was greatly diminished. However, signals were preserved when EcR was knocked down in neurons, leading us to infer that glia, in particular cortex glia, are the major site of expression (Figure 4B). Although not evident in these images, EcR expression was also detected in surface glia of the blood–brain barrier (BBB) (data not shown).

Figure 4. Ecdysone receptor (EcR) is expressed in cortex glia.

Figure 4.

(A) EcR antibody DDA2.7 staining overlaps with reporter expression driven by cortex glia drivers (GMR77A03>mCD8 RFP and Np2222>mCD8 RFP), indicating that EcR is expressed in the cortex glia. EcR antibody DDA2.7 staining also shows that EcR can be nuclear or cytoplasmic. (B) EcR antibody DDA2.7 staining is preserved and still observed in the nSyb-GS>EcR RNAi flies but is almost eliminated in the Repo-GS>EcR RNAi flies compared with the vehicle control flies. N = 10 per group. Scale bar: 100 µm. (C) Quantification of antibody staining in the fly brains’ cortex glia layer, see also Figure 4—source data 1. Signal strength was scored manually based on the fluorescence intensity in the cortex glia region. Repo-GS>EcR RNAi #1 flies have significantly reduced staining based on an unpaired parametric Student’s t-test. Bar graphs show mean ± standard error of the mean (SEM) and ns = not significant, p > 0.05, **p < 0.01.

Figure 4—source data 1. Quantification of Anti-EcR staining in the cortex glia layer.

To determine whether sleep phenotypes correlate with the expression pattern of EcR, we then knocked down EcR constitutively in different glial subpopulations by crossing subglial Gal4 lines with the EcR RNAi #1 line that targets all EcR isoforms. However, EcR knockdown with most of these Gal4 lines caused failure of eclosion, indicating the importance of EcR in glial cells during development. Three Gal4 lines produced viable adult flies: one cortex glia-specific driver GMR77A03, one astrocyte-like glia-specific driver Eaat-1, and one ensheathing glia-specific driver GMR56F03. Of these three Gal4 lines, sleep was only reduced when EcR was knocked down using the cortex glia-specific driver (Figure 5A, C).

Figure 5. Ecdysone receptor (EcR) functions in cortex glia to affect sleep.

(A) Multiple constitutive Gal4 drivers labeling different subglial populations were crossed to EcR RNAi flies. Only GMR77A03 for cortex glia (CG), Eaat-1 for astrocyte-like glia (ALG), and GMR56F03 for ensheathing glia (EG) drivers produced viable adult progeny flies, and only GMR77A03>EcR RNAi #1 flies showed reduced total sleep compared with control flies. Green chart columns are experimental groups, and neighboring black and gray columns are Gal4 and UAS flies controls, respectively. N = 16–20 per genotype. (B) Overexpression of EcR by subglial Gal4 drivers—9-137 Gal4 to drive expression in the surface glia (SG), Moody-Gal4 for subperineurial glia (SPG), GMR85G01 for perineurial glia (PG), MZ008-Gal4 for ensheathing glia (EG), GMR77A03 for cortex glia (CG), and Eaat-1 for astrocyte-like glia (ALG). Only overexpression of EcR in the surface glia promotes sleep. N = 16–24 per genotype. (C) Representative sleep traces of the cortex glia GMR77A03>EcR RNAi #1 flies. (D) Gal4/Tubulin-gal80ts was used to achieve adult-specific knockdown of EcR in different subglial populations. Under permissive temperature, Gal80ts inhibits Gal4 activation of UAS, but under restrictive temperature, Gal80ts is inactivated, and genes under the regulation of UAS are expressed. (E, F) Sleep traces resulting from EcR knockdown in the cortex glia using NP2222-Gal4/tubulinGal80ts and surface glia using 9-137 Gal4/tubulinGal80ts. F1 progeny flies were kept at 18 degrees for 1 day, and then the temperature was switched to 31 degrees to inactivate the Gal80ts and thus achieve knockdown of EcR over the following 2 days. Subsequently, temperatures were decreased back to 18 degrees. (G, H) show quantification of total sleep of all EcR knockdown flies in the cortex glia using NP2222-Gal4/tubulinGal80ts and surface glia using 9-137 Gal4/tubulinGal80ts, N = 34–77 per genotype. Total sleep of each genotype was calculated and compared to controls for the above 4 days. Bar graphs show mean ± standard error of the mean (SEM), ns = not significant, p > 0.05, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. p values for each comparison were calculated by one-way analysis of variance (ANOVA) with Tukey post hoc test. See also Figure 5—source data 1.

Figure 5—source data 1. Sleep phenotypes resulting from subglial knockdown of ecdysone receptor (EcR).
Figure 5—source data 2. Sleep phenotypes of adult-specific ecdysone receptor (EcR) disruption in different subglial populations.

Figure 5.

Figure 5—figure supplement 1. Adult-specific disruption of ecdysone receptor (EcR) in most subglial populations does not affect sleep.

Figure 5—figure supplement 1.

Temperature-sensitive tubulin-Gal80ts were used to restrict the expression of Gal4 to adults. Sleep was monitored for 1 day at the permissive temperature of 18 degrees, then 2 days at the restrictive temperature of 31 degrees data, and then for another day at 18 degrees. EcR knockdown (RNAi) and overexpression (OE) were driven by: (A, B) a cortex glia driver (NP2222>EcR RNAi #1 and NP2222>EcR OE); (C, D) a surface glia driver (9-137>EcR RNAi #1 and 9-137>EcR OE). (E, F) An astrocyte-like glia driver (Eaat-1>EcR RNAi #1 and Eaat-1>EcR OE). (G, H) An ensheathing glia driver (MZ0709>EcR RNAi #1 and MZ0709>EcR OE). Bar graphs show mean + standard error of the mean (SEM); ns = not significant, p > 0.05, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. p values for each comparison were calculated by one-way analysis of variance (ANOVA) with the Tukey post hoc test. See also Figure 5—source data 2.

To avoid issues of lethality and to distinguish between developmental and adult-specific roles, we used the TARGET system to repress Gal4 transcription in the developmental stage, after which the flies were transferred to a (restrictive) elevated temperature to degrade temperature-sensitive GAL80ts and allow expression of Gal4 (Figure 5D, McGuire et al., 2004). At the (permissive) low temperature, when TUB-GAL80ts blocks Gal4 expression, flies expressing EcR RNAi flies with the cortex glia driver NP2222 trended toward reduced sleep but sleep decreased significantly at the restrictive temperature when RNAi expression was activated to knock down EcR in cortex glia (Figure 5E, G). Knockdown of EcR with the 9-137 Gal4 driver, which targets all glia of the BBB, did not affect sleep (Figure 5F, H), and nor did knockdown of EcR in ensheathing or astrocyte glia (Figure 5—figure supplement 1), suggesting that effects of EcR on sleep are restricted to specific glia, with cortex glia being the primary physiological site of action.

We also overexpressed EcR using the same set of subglia drivers and found that only flies expressing EcR with the 9-137 Gal4 driver had elevated sleep (Figure 5B). These flies were also resistant to sleep deprivation, indicating enhanced sleep need. Restricting overexpression to the adult stage with TubGal80 did not affect sleep, suggesting that the sleep-promoting effect observed in 9-137 Gal4 flies is developmental (Figure 5—figure supplement 1D).

Ecdysone modulates sleep by mobilizing lipid droplets in glial cells

The cortex glia, especially the superficial cortex glial cells, are enriched in lipid droplets (LDs) in the third instar larval stage, and ecdysone signaling can mobilize these lipids when needed (Kis et al., 2015). To determine whether ecdysone in adult flies has a similar effect on lipids, we assayed LDs in glial cells of flies fed ecdysone. We measured LDs in the fly brain by BODIPY staining and found that LDs, which accumulate mostly in the cortex and ensheathing glia, were significantly smaller in flies fed ecdysone, relative to control groups, at Zeitgeber Time (ZT)12. At the same time, the total count was not affected (Figure 6A–D). Given that ecdysone feeding mobilizes LDs, we speculated that glial EcR knockdown might cause flies to accumulate more lipids. We performed lipid staining, comparing vehicle controls and RU486-induced groups of Repo-GS>EcR RNAi flies (Figure 6—figure supplement 1A–D), and found that EcR knockdown in glial cells resulted in more LDs, RU treatment of UAS control flies had no effect, together suggesting that ecdysone signaling bidirectionally affects LDs in glial cells. Increased sleep with ecdysone feeding reduces LDs while reduced sleep with loss of ecdysone signaling increases LDs.

Figure 6. Lipid metabolism mediates the effects of 20E on sleep.

(A, B) Lipid droplet (LD) staining of representative brains from flies treated with vehicle or 0.5 mM 20E. A z-stack slice that shows the maximal structure of the cortex glia was selected, and brightness and contrast were auto-adjusted by ImageJ for better visualization. LDs are stained by the lipophilic dye BODIPY 493. (C, D) 0.5 mM 20E treatment does not significantly affect the total count of LDs but likely mobilizes lipids to lead to smaller LDs. LD count and size were analyzed and calculated using ImageJ as detailed in the Materials and methods. N = 16 per group from two independent repeats. Statistical comparisons used unpaired parametric Student’s t-test. Bar graphs show mean ± standard error of the mean (SEM) and ns = not significant, p > 0.05, ****p < 0.0001. (E) A representative sleep trace of lsd2 mutant flies with vehicle control or 0.2 mM ecdysone. As previously reported, total sleep increases with 20E treatment in wCS,but the sleep-promoting effect of the 20E is lost in the lsd2 mutant flies, N = 16 per group from two separate experiments. Statistical comparisons used unpaired parametric Student’s t-test. See also Figure 6—source data 1.

Figure 6—source data 1. The effects of ecdysone on lipid droplets and sleep.
Figure 6—source data 2. Lipid droplets changes resulting from glial ecdysone receptor (EcR) knockdown.
Figure 6—source data 3. Sleep phenotypes of gaboxadol treatment in lsd-2 mutant flies.

Figure 6.

Figure 6—figure supplement 1. EcR knockdown in glial cells resulted in more LDs.

Figure 6—figure supplement 1.

(A, B) Lipid droplet (LD) staining of representative brains from UAS-EcR RNAi #1 control flies and Repo-GS>EcR RNAi #1 flies treated with vehicle or RU486. A z-stack slice that shows the maximal structure of the cortex glia was selected, and brightness and contrast were auto-adjusted by ImageJ for better visualization. LDs are stained by the lipophilic dye BODIPY 493. (C, D) Both LDs count and size are not significantly different between vehicle- and RU486-treated UAS-EcR RNAi #1 control flies, but LDs counts are significantly higher in the RU+Repo-GS>EcR RNAi #1 flies compared with RU− control group. N = 14–16 per group from two independent repeats. Statistical comparisons used unpaired parametric Student’s t-test. Bar graphs show mean + standard error of the mean (SEM) and ns = not significant, p > 0.05, ****p < 0.0001. See also Figure 6—source data 2.
Figure 6—figure supplement 2. Gaboxadol promotes sleep in lsd-2 mutant flies.

Figure 6—figure supplement 2.

A representative sleep trace of lsd-2 mutant flies with vehicle control or 0.1 mg/ml gaboxadol is shown in the left panel and quantification of all data points are shown on the right. N = 37–38 per group from three separate experiments. Statistical comparisons used unpaired parametric Student’s t-test. Bar graphs show mean + standard error of the mean (SEM) and ns = not significant, p > 0.05, ****p < 0.0001. See also Figure 6—source data 3.
Figure 6—figure supplement 3. Model for sleep function of ecdysone in cortex glia.

Figure 6—figure supplement 3.

This schematic shows how ecdysone acts as a long-distance signal to affect sleep in cortex glia. Ecdysone synthesis genes are not expressed in the fly brain, suggesting that glial ecdysone comes from the periphery. Glial knockdown of ecdysone receptor (EcR) and its downstream target E75 reduces sleep. Ecdysone promotes sleep by mobilizing lipid droplets stored mainly in glia, and knockdown of glial EcR results in more lipid droplets.

We next asked if this effect on lipids was relevant for sleep induction by ecdysone by measuring the ecdysone response of a lipid storage mutant (Kamoshida et al., 2012). The lipid storage droplet 2 (LSD2) protein modulates lipid accumulation and response to starvation, so lsd2 mutants are lean and sensitive to starvation (Thimgan et al., 2010). We found that ecdysone does not promote sleep in lsd2 mutants (Figure 6E). However, feeding lsd-2 mutant flies gaboxadol, a GABA agonist known to induce deep sleep, significantly increased sleep (Figure 6—figure supplement 2), indicating that non-responsiveness to ecdysone was not due to an inability of lsd-2 flies to respond to sleep-promoting interventions. Lack of a sleep-promoting effect of ecdysone on lsd-2 mutants, together with bidirectional effects of ecdysone on LDs, indicate strongly that ecdysone affects sleep in large part by modulating LDs in glial cells, especially cortex glia (Figure 6—figure supplement 3).

Discussion

While sleep traditionally has been regarded as a neuronally driven behavior, glial cells can regulate sleep by affecting neuronal activity and possibly even mediate functions attributed to sleep, such as waste clearance, nutrient transfer, and repair (Cai et al., 2021; Donlea et al., 2014; Keene et al., 2010; Chi-Castañeda and Ortega, 2016; Seidner et al., 2015; Singh and Donlea, 2020; Stanhope et al., 2020; Yildirim et al., 2019). We show here that glia are also a major target of steroid hormone signaling to regulate sleep. In addition, our data support an important role for lipid metabolism in controlling sleep.

In Drosophila, ecdysone is the major steroid hormone, and it plays an essential role in regulating metamorphosis and molting (Yamanaka et al., 2013). Ecdysone also affects the development of the nervous system and neuronal remodeling, processes that may involve glial function (Yu and Schuldiner, 2014). During development, ecdysone is synthesized from dietary cholesterol in the prothoracic gland and in other peripheral tissues that control molting and eclosion in larvae and pupae, but it declines during pupa-adult transitions and remains low in adults (Yamanaka et al., 2013; Kannangara et al., 2021). Nevertheless, it is implicated in adult functions such as memory formation and stress resistance (Ishimoto and Kitamoto, 2011). Ecdysone was also shown to affect sleep (Ishimoto and Kitamoto, 2011), raising questions of the mechanism by which it does so and the cells on which it acts in adults. Our finding that ecdysone regulates sleep through metabolic mechanisms in glia is consistent with other metabolic functions attributed to it; for instance, it controls developmental transitions in response to nutrient signals (Christensen et al., 2020; Lee et al., 2000; Uyehara and McKay, 2019; Xu et al., 2020; Yamanaka et al., 2013). Indeed, ecdysone may affect the whole-body lipid profile to modulate physiology and behavior (Sieber and Spradling, 2015).

The gonads, in particular the ovaries in females, are thought to be the major source of the ecdysone in adults (Ahmed et al., 2020). However, several other tissues also express ecdysone biosynthesis genes (Li et al., 2022), so multiple peripheral tissues could contribute to circulating ecdysone levels. Consistent with this notion, our efforts to observe sleep changes by disrupting the synthesis of ecdysone in any one of the following peripheral tissues—gut, fat body, and ovary—failed (data not shown). We speculate that knockdown of biosynthetic enzymes in any one peripheral tissue does not have a significant effect because ecdysone can still be derived from other tissues. Notably, knockdown in the brain did not have any effect either. Also, Halloween genes have very little to no expression in the fly brain based on fly brain single-cell sequencing (Davie et al., 2018), suggesting that ecdysone or 20E derives from the periphery to modulate sleep via glia.

In Drosophila, around 10–15% of cells in the brain are glial cells belonging to one of five distinct groups: cortex glia, astrocyte-like glia, ensheathing glia, perineurial, and subperineural glia (Edwards and Meinertzhagen, 2010; Yildirim et al., 2019). Perineurial and subperineural glia together serve as the BBB regulating permeability, controlled by the circadian system (Zhang et al., 2018). BBB glia also have a role in sleep, such that endocytosis in these cells increases during sleep and depends upon the prior duration of wakefulness (Artiushin et al., 2018). Astrocyte-like glia have a distinctive shape that allows remarkably close physical contact with synapses and is thought to be important for the clearance of neurotransmitters in the synaptic space (Freeman, 2015). In support of this, arylalkylamine N-acetyltransferase 1 (AANAT1), which acetylates and inactivates monoamines, acts in astrocytes to affect sleep (Davla et al., 2020). Also, calcium signaling in astrocytes appears to contribute to sleep need (Blum et al., 2021), and astrocytic GABA transporter maintains proper GABA tone in specific wake-promoting circadian neurons (Chaturvedi et al., 2022). Cortex glia cells encapsulate neuronal cell bodies and provide nutrients to neurons (Doherty et al., 2009). Cortex and ensheathing glia accumulate most LDs in the brain, and fatty acid-binding protein (Fabp), which promotes sleep, is expressed in both glial populations (Gerstner et al., 2011). In addition, ensheathing glia regulate both sleep and metabolic rate via the taurine transporter (Stahl et al., 2018). Thus, roles of cortex and ensheathing glia in sleep are likely linked to their function in metabolic, which includes nutrient transfer and balance between neurons and glia (Bittern et al., 2021). We note though that the effects of Amyloid precursor protein (App), which regulates the production and deposition of toxic amyloid peptides, on sleep are mediated by cortex glia (Farca Luna et al., 2017).

We show here that the ecdysone signaling pathway functions in adult cortex glia and neurons to affect circadian locomotor rhythms and sleep. The specific cellular targets through which ecdysone regulates sleep were previously not known. Additionally, while ecdysone can regulate circadian rhythms through neuronally expressed receptors (Kumar et al., 2014), we find that knockdown of glial EcRs results in more severe behavioral arrhythmicity than neuronal knockdown (Figure 2I–K). As Drosophila astrocytes regulate circadian locomotor rhythms (Ng et al., 2011), they are attractive candidates for mediating the effects of ecdysone on rhythms. Our finding that EcR in specific subglial cells is also vital to the development of flies is surprising even though NHRs have well-documented roles in development. Ecdysone treatment upregulates the gene glial cell missing (gcm), while knockdown of EcR reduces the expression of gcm in vitro, suggesting that ecdysone influences the development and morphology of glial cells by regulating gcm, which determines the fate of the lateral glial cells (Wang et al., 2014). Thus, glia are an important target for biological actions of ecdysone on development and adult behavior.

We show that exogenous ecdysone mobilizes lipids accumulated in cortex glia to promote sleep, and glial EcR knockdown results in the accumulation of LDs. Since cortex glia cells surround and compartmentalize neuronal cell bodies, they may modulate neuronal activity by facilitating metabolite transfer to neurons. Aside from cortex glia, the only glial type to yield a phenotype with manipulations of ecdysone signaling is the surface glia. The sleep phenotype by EcR overexpression in surface glia may be non-physiological as a strong Gal4 line produces it, but it nevertheless suggests that the surface glia can support ecdysone signaling.

Our finding that lipid metabolism is important for ecdysone-induced sleep fits with increasing evidence of interactions between sleep and lipids. Loss of sleep alters the lipid profile across species, including in human peripheral blood (Davies et al., 2014; Hinard et al., 2012; Weljie et al., 2015). Conversely, lipids have been shown to regulate sleep; for instance, the lsd2 mutant we used here, as well as a mutant lacking a lipase, affect rebound after sleep deprivation in Drosophila (Thimgan et al., 2010). Interestingly, specific lipids are also implicated as secreted sleep inducers (somnogens) that promote sleep following deprivation in mammals (Cravatt et al., 1995). Studies in worm also showed that sleep is associated with fat mobilization, and deficits in energy mobilization in sensory neuroendocrine cells cause sleep defects (Grubbs et al., 2020).

How ecdysone synthesis is regulated and how its function is integrated with innate and environmental changes needs further study. Juvenile hormone (JH), which works together with ecdysone during developmental stages, differentially affects sleep in male and female flies (Leinwand and Scott, 2021; Schwedes and Carney, 2012; Wu et al., 2018); it is reasonable to hypothesize that JH interacts with ecdysone in the context of sleep. The human ortholog of E75 is Reverb, which has broad effects on metabolism in peripheral tissues based on work in mice and humans, so the functions of EcR/E75 in peripheral tissues may also be linked to metabolism (Ding et al., 2021; Zhang et al., 2017). In addition, Reverb has high expression in mouse brain glial cells, where it could function to affect mouse sleep (Chi-Castañeda and Ortega, 2017).

In summary, the endocrine system and the circuitry underlying circadian rhythms and sleep are intertwined during developmental stages (Aldabal and Bahammam, 2011; Gamble et al., 2014; Morgan and Tsai, 2015), and we now find that ecdysone acts through specific glial cells to affect circadian rhythms and sleep in adults. Similar effects of the ecdysone downstream target E75 and the ecdysone importer implicate canonical nuclear hormone signaling in sleep regulation. The mechanism involves LD mobilization, emphasizing the importance of glia and lipid metabolism in sleep regulation. Our findings are likely just the tip of the iceberg concerning endocrine regulation of sleep. We expect this to be a rich area of investigation in the future, as peripheral effects on brain function are increasingly recognized.

Materials and methods

See Appendix 1.

Contact for reagent and resource sharing

Further information and requests for resources and reagents should be directed to lead contact Amita Sehgal (amita@pennmedicine.upenn.edu).

Experimental model and subject details

Fly stock and maintenance

Drosophila stocks were obtained from our lab stock, Bloomington Drosophila stock center (BDSC), or the Vienna Drosophila Resource Center (VDRC). The white-CantonS (wCS) strain was used as wild-type unless specified. The genotype information of the flies used in each experiment is listed in the Key resource table. Strains used from the lab stocks include nSyb-GeneSwitch, Repo-GeneSwitch, all the subglial lines, and four subglial tubGal80ts lines. nSyb-GeneSwitch, Repo-GeneSwitch experiments were conducted with UAS-Dcr2 to promote RNAi efficiency. EcR RNAi lines are from the lab stock originally purchased from VDRC. The lsd-2 flies were gifts from Dr. Michael Welts lab, and EcI lines were gifts from Dr. Naoki Yamanaka lab.

Behavior measurement in Drosophila

Flies were raised on cornmeal-molasses medium under 12:12 hr light:dark cycle at 25°C unless specified otherwise. Twelve female virgins and four male flies were usually crossed together to generate different flies of genotypes. Parental flies were cleared after seven days, and F1 progeny collected after 12 days. On day17, 5- to 7-day-old female flies were loaded into locomotor tubes for behavior tests as previously described (Davla et al., 2020). Locomotor tubes were 60-mm glass tubes, waxed and loaded with 2% agar containing 5% sucrose as fly food on one side, and yarn on the other side to restrain the behavior of flies inside the glass tubes. For GeneSwitch experiments, 0.5 mM RU-486 (mifepristone) was added to the fly food to activate the GeneSwitch. Three constitutive days’ data were used for sleep analysis by Pysolo (https://www.pysolo.net/) (Gilestro and Cirelli, 2009), and seven constitutive days’ data under constant dark were used for circadian rhythm analysis by ClockLab (https://actimetrics.com/products/clocklab/).

For starvation assay, starvation tubes were made with only 2% agarose as fly food. Five- to seven-day-old flies were first loaded into normal locomotor tubes for days 0 and 1, then they were transferred to starvation tubes between ZT23 and ZT0 on day 2. Flies were monitored for sleep in starvation tubes for 1 or 2 days and then transferred back to normal tubes at ZT23–ZT0. Post-starvation sleep was measured for 1 day.

Ecdysone treatment, immunohistochemistry, and imaging

Ecdysone was purchased in powder form and was dissolved in ethanol. Then it was mixed with 2% agarose containing 5% sucrose to make the different doses of ecdysone tubes, and the same amount of ethanol as in the ecdysone solution was used to make the vehicle control tubes. Only 2% agarose and ecdysone were used to make ecdysone starvation tubes. Five- to seven-day-old flies were loaded into locomotor tubes for ecdysone treatment and behavior recording to verify that ecdysone promotes sleep in ecdysone-treated flies. For ecdysone feeding/starvation assay, all flies were kept in normal tube on days 0, 1, and 2. Flies were then transferred to either starvation tubes, or ecdysone starvation tubes between ZT23 and ZT0 on day 2. Flies were kept in these ecdysone/starvation tubes for 1 day and transferred back to normal tubes again between ZT23 and ZT0 on day 3 and recorded for another day. Data from days 2 to 4 were used for sleep analysis. For gaboxadol hydrochloride treatment, it was dissolved in water and diluted to 0.1 mg/ml as final concentration for locomotor tube experiments. Sleep was measurement from days 2 to 4, after flies were loaded into gaboxadol tubes at day 0. For TARGET system experiments, flies were raised at permissive temperature 18°C, and 5- to 7-day-old adult flies were used to loaded and were kept at 18°C from days 0 to 2, 31°C from days 3 to 4, and 18°C for day 5. Data from days 2 to 5 were collected for sleep analysis.

BODIPY493 was used for brain LD staining. Flies were loaded into locomotor tubes and subjected to 0.5 mM ecdysone treatment for 12 or 36 hr. Both control and ecdysone-treated flies were then dissected in the phosphate-buffered saline (PBS), fixed in 4% Paraformaldehyde (PFA) solution for 20 min, and washed three times with PBS + 0.3% Triton (PBT). Then brains were left in PBT at 4 degrees overnight and transferred to 1 µg/ml BODIPY493 in PBT for 20 min. Later they were mounted for imaging.

Brains were imaged with the oil-immersion ×40 lens of a confocal microscope at a resolution of 1024 × 1024. Raw images were processed with FIJI ImageJ. The first step was to remove non-lipid trash and exclude artificial signals or signals outside the brain area. The second step was to quantify the LD count, area, and total brain tissue area. Later, the LDs count will be normalized by the brain tissue area, and LD size calculated by LD area divided by total count. Quantifications were conducted by using ImageJ Macro.

Ecdysone assay and real-time PCR

20E measurement was performed with the 20-hydroxyecdysone EIA kit (Cayman, item No. 501390). 5–10 fly bodies or 10–15 brains were dissected and homogenized in 70% methanol. The homogenates were then dried by the evaporator, redissolved in the kit’s buffer, and measured based on the manufacturer’s protocol. Adult fly brains (usually 10) or fly bodies (usually 5) were subjected to RNeasy Plus Mini Kit for RNA extraction, followed by cDNA reverse transcription using random hexamers and Superscript II (Invitrogen) to generate cDNA. The cDNA was then amplified using SYBR Green PCR mix (Cat# 4364346) and oligonucleotides listed in the Key resource table with the Applied Biosystems ViiA7 qPCR machine. Relative transcript levels were calculated by ddCT.

Statistical analysis

GraphPad Prism was used for all statistical tests. Data were tested for normality using the D’Agostino–Pearson test and Shapiro–Wilk test. Normally distributed data were then tested with an unpaired parametric Student’s t-test for two independent groups and a one-way analysis of variance with Tukey post hoc test for multiple independent groups. Non-normally distributed data, such as sleep bout numbers, which are usually non-normally distributed, were analyzed with a nonparametric test like the Mann–Whitney test for two samples and the Kruskal–Wallis test with Dunn’s multiple comparisons test for three samples or above. Statistic tests used for each experiment are indicated in the figure legends, and data are presented as means and standard error of the mean.

Acknowledgements

This work was supported by Howard Hughes Medical Institute (HHMI). We thank Anna Kolesnik, Joy Shon, Xanthe Heifetz Ament, Samantha Killiany, and Kiet Luu for continuing technical assistance and all other members of the Sehgal lab for feedback, comments, and reagents. The schematic was created with https://biorender.com/. We thank Dr. Michael Welts and Dr. Naoki Yamanaka for generously sharing fly lines with us.

Appendix 1

Appendix 1—key resources table.

Reagent type (species) or resource Designation Source or reference Identifiers Additional information
Genetic reagent (D. melanogaster) w[*]; P{w[+mW.hs]=Switch2}GSG2326 Bloomington Stock Center BDSC:40990
Genetic reagent (D. melanogaster) w[*]; P{y[+t7.7] w[+mC]=UAS-Eip78C.miRNA}attP16/CyO Bloomington Stock Center BDSC:44390
Genetic reagent (D. melanogaster) w[*]; P{y[+t7.7] w[+mC]=UAS Hr3.miRNA}attP16 Bloomington Stock Center BDSC:44399
Genetic reagent (D. melanogaster) w[*]; P{y[+t7.7] w[+mC]=UAS Hr96.miRNA}attP16 Bloomington Stock Center BDSC:44395
Genetic reagent (D. melanogaster) w[*]; P{y[+t7.7] w[+mC]=UAS-Hnf4.miRNA}attP16/CyO Bloomington Stock Center BDSC:44398
Genetic reagent (D. melanogaster) y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF02546}attP2 Bloomington Stock Center BDSC:27258
Genetic reagent (D. melanogaster) y[1] sc[*] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.HMS01620}attP2 Bloomington Stock Center BDSC:36729
Genetic reagent (D. melanogaster) w[*]; P{y[+t7.7] w[+mC]=UAS Hr78.miRNA}attP16 Bloomington Stock Center BDSC:44393
Genetic reagent (D. melanogaster) y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF02545}attP2 Bloomington Stock Center BDSC:27242
Genetic reagent (D. melanogaster) y[1] sc[*] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.HMS01316}attP2 Bloomington Stock Center BDSC:34329
Genetic reagent (D. melanogaster) y[1] sc[*] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.HMS01951}attP2 Bloomington Stock Center BDSC:39032
Genetic reagent (D. melanogaster) y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF02537}attP2 Bloomington Stock Center BDSC:29373
Genetic reagent (D. melanogaster) y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.HMS02272}attP40 Bloomington Stock Center BDSC:41707
Genetic reagent (D. melanogaster) w[*]; P{y[+t7.7] w[+mC]=UAS Hr83.miRNA}attP16 Bloomington Stock Center BDSC:44397
Genetic reagent (D. melanogaster) w[*]; P{y[+t7.7] w[+mC]=UAS svp.miRNA}attP16 Bloomington Stock Center BDSC:44394
Genetic reagent (D. melanogaster) w[*]; P{y[+t7.7] w[+mC]=UAS ERR.miRNA}attP16/CyO Bloomington Stock Center BDSC:44391
Genetic reagent (D. melanogaster) w[*]; P{y[+t7.7] w[+mC]=UAS Hr38.miRNA}attP16/CyO Bloomington Stock Center BDSC:44396
Genetic reagent (D. melanogaster) y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF02738}attP2 Bloomington Stock Center BDSC:27659
Genetic reagent (D. melanogaster) y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.HMS00019}attP2/TM3, Sb[1] Bloomington Stock Center BDSC:33625
Genetic reagent (D. melanogaster) y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.HMS00018}attP2/TM3, Sb[1] Bloomington Stock Center BDSC:33624
Genetic reagent (D. melanogaster) y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF02432}attP2 Bloomington Stock Center BDSC:27086
Genetic reagent (D. melanogaster) w[*]; P{y[+t7.7] w[+mC]=UAS Hr4.miRNA}attP16 Bloomington Stock Center BDSC:44392
Genetic reagent (D. melanogaster) y[1] w[*]; PBac{y[+mDint2] w[+mC]=I-SceI(FRT.Rab9-GAL4.ATG(loxP.3xP3-RFP))}VK00033/TM3, Sb[1] Bloomington Stock Center BDSC:51587
Genetic reagent (D. melanogaster) w;; Repo-Gal4, 6 x crossed to Iso Bloomington Stock Center BDSC:7415
Genetic reagent (D. melanogaster) w[1118]; UAS-EcR.A.dsRNA/TM3 Bloomington Stock Center BDSC:9328
Genetic reagent (D. melanogaster) w[1118]; P{w[+mC]=UAS EcR.B1.dsRNA}168 Bloomington Stock Center BDSC:9329
Genetic reagent (D. melanogaster) w[*]; P{w[+mC]=UAS EcR.A.F645A}TP2 Bloomington Stock Center BDSC:9452
Genetic reagent (D. melanogaster) y1 v1; P{TRiP.JF02257}attP2 Bloomington Stock Center BDSC:26717
Genetic reagent (D. melanogaster) w[1118]; P{w[+mC]=hs-GAL4-EcR.LBD}SBM Bloomington Stock Center BDSC:23656
Genetic reagent (D. melanogaster) w; UAS-GFP-Lsd2 Michael Welte
Genetic reagent (D. melanogaster) w;; UAS-EcI RNAi Naoki Yamanaka BDSC:37295
Genetic reagent (D. melanogaster) w1118; P{GD1434}v44851 VDRC Stock Center VDRC:44851
Genetic reagent (D. melanogaster) w1118; P{GD1428}v37058 VDRC Stock Center VDRC:37058
Genetic reagent (D. melanogaster) w1118; P{GD1428}v37059 VDRC Stock Center VDRC:37059
Genetic reagent (D. melanogaster) UAS-E75 RNAi GD VDRC Stock Center VDRC:44851
Genetic reagent (D. melanogaster) UAS-E75 RNAi KK VDRC Stock Center VDRC:108399
Genetic reagent (D. melanogaster) white Canton-S Laboratory Stocks
Genetic reagent (D. melanogaster) nSyb-GS74 Laboratory Stocks PMID: 29590612
Genetic reagent (D. melanogaster) Repo-GS11 Laboratory Stocks
Genetic reagent (D. melanogaster) Actin-GS Laboratory Stocks
Genetic reagent (D. melanogaster) w[*]; P{w[+mW.hs]=Switch2}GSG5961 Laboratory Stocks
Genetic reagent (D. melanogaster) w; 9–137 Gal4; TubGal80ts Laboratory Stocks
Genetic reagent (D. melanogaster) w; MZ0708-Gal4; TubGal80ts Laboratory Stocks
Genetic reagent (D. melanogaster) w; Eaat1-Gal4; TubGal80ts Laboratory Stocks
Genetic reagent (D. melanogaster) w; TubGal80ts; NP222-Gal4 Laboratory Stocks
Genetic reagent (D. melanogaster) w; NP2222-Gal4 Laboratory Stocks
Genetic reagent (D. melanogaster) w; GMR85601-Gal4 Laboratory Stocks
Genetic reagent (D. melanogaster) w; Eaat1-Gal4;;, 6 x crossed to Iso Laboratory Stocks
Genetic reagent (D. melanogaster) w; GMR56F03-Gal4 Laboratory Stocks
Genetic reagent (D. melanogaster) w; NP6293-Gal4, 6 x crossed to Iso Laboratory Stocks
Genetic reagent (D. melanogaster) w; Alarm-Gal4 Laboratory Stocks
Genetic reagent (D. melanogaster) w; 9–137 Gal4; 6 x crossed to Iso Laboratory Stocks
Genetic reagent (D. melanogaster) w; MZ0709-Gal4 Laboratory Stocks
Genetic reagent (D. melanogaster) w; moody-Gal4, 6 x crossed to Iso Laboratory Stocks
Genetic reagent (D. melanogaster) w; TublinGal80ts/CYO; Repo-Gal4/TM6 Laboratory Stocks
Antibody EcR Antibody DDA2.7 (mouse monoclonal) Developmental Studies Hybridoma Bank (DSHB) DDA2.7 (EcR common) 2 ug/ml
Sequence-based reagent E74_FOR This paper, Integrated DNA Technologies PCR primers TGA GAC GCG AGG AAT ACC CTG GAC
Sequence-based reagent E74_REV This paper, Integrated DNA Technologies PCR primers AAC TGC CAG CGT GTA GCC GTT TCC
Sequence-based reagent E75A_FOR This paper, Integrated DNA Technologies PCR primers TCA GCA GGC CAA TCT GCA CCA CTC
Sequence-based reagent E75A_REV This paper, Integrated DNA Technologies PCR primers TGA TGT ACT CGG GAG TCT GGG GAC
Sequence-based reagent E75B_FOR This paper, Integrated DNA Technologies PCR primers AGC AGC ACC AGC ACC AGC AAC AAC
Sequence-based reagent E75B_REV This paper, Integrated DNA Technologies PCR primers ATT GCC CGC ACT GGA GTT GCT CGA
Sequence-based reagent EcI_FOR This paper, Integrated DNA Technologies PCR primers TGC AGT GCC GCT CTC AAC TGT ACC
Sequence-based reagent EcI_REV This paper, Integrated DNA Technologies PCR primers TCA CAG TAA CCG TTG ACC GCC TCC
Sequence-based reagent EcR_C_FOR This paper, Integrated DNA Technologies PCR primers TCA ACC ACA GCC ACA GCT CCT TCC
Sequence-based reagent EcR_C_REV This paper, Integrated DNA Technologies PCR primers TGA TGG GTC CTA TGG CCG CAC TTC
Sequence-based reagent EcR_1_FOR This paper, Integrated DNA Technologies PCR primers GCG GCC AAG ACT TTG TTA AG
Sequence-based reagent EcR_1_REV This paper, Integrated DNA Technologies PCR primers GGC CAA CTG ATT GTA CGT TAA G
Sequence-based reagent EcR_2_FOR This paper, Integrated DNA Technologies PCR primers GCC ATC TGA AGA GGA TCT CAG
Sequence-based reagent EcR_2_REV This paper, Integrated DNA Technologies PCR primers AAC GCT GGT AGA CCT TTA GC
Commercial assay or kit 20-Hydroxyecdysone EIA kit Cayman Item No. 501390
Commercial assay or kit RNeasy Plus Mini Kit Qiagen Item No. 74134
Chemical compound, drug BODIPY 493/503 Fisher D3922 1 ug/ml
Chemical compound, drug 20-Hydroxyecdysone Sigma H5142 0.5 mM
Chemical compound, drug Gaboxadol Sigma-Aldrich T101 0.1 mg/ml
Software, algorithm Clocklab Actimetrics https://actimetrics.com/
Software, algorithm Adobe Illustrator 2020 Adobe https://www.adobe.com/
Software, algorithm BioRender BioRender App.biorender.com
Software, algorithm Pysolo Gilestro and Cirelli, 2009 https://www.pysolo.net/about/
Software, algorithm GraphPad Prism v9 GraphPad Software https://www.graphpad.com/
Software, algorithm JTK_CYCLE Hughes et al., 2010 Hughes et al., 2010
Software, algorithm DAMFileScan113 Trikinetics https://trikinetics.com/

Funding Statement

The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication.

Contributor Information

Amita Sehgal, Email: amita@pennmedicine.upenn.edu.

Mani Ramaswami, Trinity College Dublin, Ireland.

K VijayRaghavan, National Centre for Biological Sciences, Tata Institute of Fundamental Research, India.

Funding Information

This paper was supported by the following grants:

  • Howard Hughes Medical Institute to Amita Sehgal.

  • National Institute of Neurological Disorders and Stroke R01NS048471 to Amita Sehgal.

  • National Institutes of Health R01DK120757 to Amita Sehgal.

Additional information

Competing interests

No competing interests declared.

No competing interests declared.

Author contributions

Conceptualization, Resources, Data curation, Software, Formal analysis, Supervision, Validation, Investigation, Visualization, Methodology, Writing – original draft, Project administration, Writing – review and editing.

Resources, Data curation, Software, Formal analysis, Methodology, Writing – review and editing.

Resources, Software, Formal analysis, Supervision, Investigation, Methodology.

Resources, Data curation, Methodology.

Conceptualization, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Project administration, Writing – review and editing.

Additional files

MDAR checklist

Data availability

All data analyzed and reported in this study are included in the manuscript, supplementary tables, and source data linked to figures.

References

  1. Abruzzi KC, Rodriguez J, Menet JS, Desrochers J, Zadina A, Luo W, Tkachev S, Rosbash M. Drosophila clock target gene characterization: implications for circadian tissue-specific gene expression. Genes & Development. 2011;25:2374–2386. doi: 10.1101/gad.178079.111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ahmed SMH, Maldera JA, Krunic D, Paiva-Silva GO, Pénalva C, Teleman AA, Edgar BA. Fitness trade-offs incurred by ovary-to-gut steroid signalling in Drosophila. Nature. 2020;584:415–419. doi: 10.1038/s41586-020-2462-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Aldabal L, Bahammam AS. Metabolic, endocrine, and immune consequences of sleep deprivation. The Open Respiratory Medicine Journal. 2011;5:31–43. doi: 10.2174/1874306401105010031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Anafi RC, Pellegrino R, Shockley KR, Romer M, Tufik S, Pack AI. Sleep is not just for the brain: transcriptional responses to sleep in peripheral tissues. BMC Genomics. 2013;14:e362. doi: 10.1186/1471-2164-14-362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Anafi RC, Kayser MS, Raizen DM. Exploring phylogeny to find the function of sleep. Nature Reviews. Neuroscience. 2018;20:109–116. doi: 10.1038/s41583-018-0098-9. [DOI] [PubMed] [Google Scholar]
  6. Artiushin G, Zhang SL, Tricoire H, Sehgal A. Endocytosis at the Drosophila blood-brain barrier as a function for sleep. eLife. 2018;7:18. doi: 10.7554/eLife.43326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Beuchle D, Jaumouillé E, Nagoshi E. The nuclear receptor unfulfilled is required for free-running clocks in Drosophila pacemaker neurons. Current Biology. 2012;22:1221–1227. doi: 10.1016/j.cub.2012.04.052. [DOI] [PubMed] [Google Scholar]
  8. Bittern J, Pogodalla N, Ohm H, Brüser L, Kottmeier R, Schirmeier S, Klämbt C. Neuron-glia interaction in the Drosophila nervous system. Developmental Neurobiology. 2021;81:438–452. doi: 10.1002/dneu.22737. [DOI] [PubMed] [Google Scholar]
  9. Blum ID, Keleş MF, Baz E-S, Han E, Park K, Luu S, Issa H, Brown M, Ho MCW, Tabuchi M, Liu S, Wu MN. Astroglial calcium signaling encodes sleep need in Drosophila. Current Biology. 2021;31:150–162. doi: 10.1016/j.cub.2020.10.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bonora E, DeFronzo R. In: Principles of Endocrinology and Hormone Action. Endocrinology. Belfiore A, LeRoith D, editors. Springer; 2018. Steroid hormones: synthesis, secretion, and transport; pp. 1–31.http://link.springer.com/10.1007/978-3-319-27317-4 [DOI] [Google Scholar]
  11. Borbély AA, Daan S, Wirz-Justice A, Deboer T. The two-process model of sleep regulation: A reappraisal. Journal of Sleep Research. 2016;25:131–143. doi: 10.1111/jsr.12371. [DOI] [PubMed] [Google Scholar]
  12. Borniger JC, de Lecea L. Peripheral lipopolyssacharide rapidly silences REM-active LHGABA neurons. Frontiers in Behavioral Neuroscience. 2021;15:26. doi: 10.3389/fnbeh.2021.649428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Cai XT, Li H, Borch Jensen M, Maksoud E, Borneo J, Liang Y, Quake SR, Luo L, Haghighi P, Jasper H. Gut cytokines modulate olfaction through metabolic reprogramming of glia. Nature. 2021;596:97–102. doi: 10.1038/s41586-021-03756-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Chaturvedi R, Stork T, Yuan C, Freeman MR, Emery P. Astrocytic GABA transporter controls sleep by modulating GABAergic signaling in Drosophila circadian neurons. Current Biology. 2022;32:1895–1908. doi: 10.1016/j.cub.2022.02.066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Chi-Castañeda D, Ortega A. Clock genes in glia cells: a rhythmic history. ASN Neuro. 2016;8:1759091416670766. doi: 10.1177/1759091416670766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Chi-Castañeda D, Ortega A. The role of mammalian glial cells in circadian rhythm regulation. Neural Plasticity. 2017;2017:8140737. doi: 10.1155/2017/8140737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Christensen CF, Koyama T, Nagy S, Danielsen ET, Texada MJ, Halberg KA, Rewitz K. Ecdysone-dependent feedback regulation of prothoracicotropic hormone controls the timing of developmental maturation. Development. 2020;147:dev188110. doi: 10.1242/dev.188110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Chua ECP, Shui G, Cazenave-Gassiot A, Wenk MR, Gooley JJ. Changes in plasma lipids during exposure to total sleep deprivation. Sleep. 2015;38:1683–1691. doi: 10.5665/sleep.5142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Cravatt BF, Prospero-Garcia O, Siuzdak G, Gilula NB, Henriksen SJ, Boger DL, Lerner RA. Chemical characterization of a family of brain lipids that induce sleep. Science. 1995;268:1506–1509. doi: 10.1126/science.7770779. [DOI] [PubMed] [Google Scholar]
  20. Davie K, Janssens J, Koldere D, De Waegeneer M, Pech U, Kreft Ł, Aibar S, Makhzami S, Christiaens V, Bravo González-Blas C, Poovathingal S, Hulselmans G, Spanier KI, Moerman T, Vanspauwen B, Geurs S, Voet T, Lammertyn J, Thienpont B, Liu S, Konstantinides N, Fiers M, Verstreken P, Aerts S. A single-cell transcriptome atlas of the aging Drosophila brain. Cell. 2018;174:982–998. doi: 10.1016/j.cell.2018.05.057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Davies SK, Ang JE, Revell VL, Holmes B, Mann A, Robertson FP, Cui N, Middleton B, Ackermann K, Kayser M, Thumser AE, Raynaud FI, Skene DJ. Effect of sleep deprivation on the human metabolome. PNAS. 2014;111:10761–10766. doi: 10.1073/pnas.1402663111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Davla S, Artiushin G, Li Y, Chitsaz D, Li S, Sehgal A, van Meyel DJ. AANAT1 functions in astrocytes to regulate sleep homeostasis. eLife. 2020;9:18. doi: 10.7554/eLife.53994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. DeSalvo MK, Hindle SJ, Rusan ZM, Orng S, Eddison M, Halliwill K, Bainton RJ. The Drosophila surface glia transcriptome: evolutionary conserved blood-brain barrier processes. Frontiers in Neuroscience. 2014;8:346. doi: 10.3389/fnins.2014.00346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Ding G, Li X, Hou X, Zhou W, Gong Y, Liu F, He Y, Song J, Wang J, Basil P, Li W, Qian S, Saha P, Wang J, Cui C, Yang T, Zou K, Han Y, Amos CI, Xu Y, Chen L, Sun Z. Rev-Erb in GABAergic neurons controls diurnal hepatic insulin sensitivity. Nature. 2021;592:763–767. doi: 10.1038/s41586-021-03358-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Doherty J, Logan MA, Taşdemir OE, Freeman MR. Ensheathing glia function as phagocytes in the adult Drosophila brain. The Journal of Neuroscience. 2009;29:4768–4781. doi: 10.1523/JNEUROSCI.5951-08.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Donlea JM, Pimentel D, Miesenböck G. Neuronal machinery of sleep homeostasis in Drosophila. Neuron. 2014;81:860–872. doi: 10.1016/j.neuron.2013.12.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Dubowy C, Sehgal A. Circadian rhythms and sleep in Drosophila melanogaster. Genetics. 2017;205:1373–1397. doi: 10.1534/genetics.115.185157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Edwards TN, Meinertzhagen IA. The functional organisation of glia in the adult brain of Drosophila and other insects. Progress in Neurobiology. 2010;90:471–497. doi: 10.1016/j.pneurobio.2010.01.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Ehlen JC, Brager AJ, Baggs J, Pinckney L, Gray CL, DeBruyne JP, Esser KA, Takahashi JS, Paul KN. Bmal1 function in skeletal muscle regulates sleep. eLife. 2017;6:557. doi: 10.7554/eLife.26557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Farca Luna AJ, Perier M, Seugnet L. Amyloid precursor protein in Drosophila glia regulates sleep and genes involved in glutamate recycling. The Journal of Neuroscience. 2017;37:4289–4300. doi: 10.1523/JNEUROSCI.2826-16.2017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Freeman MR. Drosophila central nervous system glia. Cold Spring Harbor Perspectives in Biology. 2015;7:a020552. doi: 10.1101/cshperspect.a020552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Gamble KL, Berry R, Frank SJ, Young ME. Circadian clock control of endocrine factors. Nature Reviews. Endocrinology. 2014;10:466–475. doi: 10.1038/nrendo.2014.78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Gerstner JR, Vanderheyden WM, Shaw PJ, Landry CF, Yin JCP. Fatty-Acid binding proteins modulate sleep and enhance long-term memory consolidation in Drosophila. PLOS ONE. 2011;6:e15890. doi: 10.1371/journal.pone.0015890. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Gilestro GF, Cirelli C. PySolo: a complete suite for sleep analysis in Drosophila. Bioinformatics. 2009;25:1466–1467. doi: 10.1093/bioinformatics/btp237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Grubbs JJ, Lopes LE, van der Linden AM, Raizen DM. A salt-induced kinase is required for the metabolic regulation of sleep. PLOS Biology. 2020;18:e3000220. doi: 10.1371/journal.pbio.3000220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Harbison ST, Mackay TFC, Anholt RRH. Understanding the neurogenetics of sleep: progress from Drosophila. Trends in Genetics. 2009;25:262–269. doi: 10.1016/j.tig.2009.04.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Hill VM, O’Connor RM, Sissoko GB, Irobunda IS, Leong S, Canman JC, Stavropoulos N, Shirasu-Hiza M. A bidirectional relationship between sleep and oxidative stress in Drosophila. PLOS Biology. 2018;16:e2005206. doi: 10.1371/journal.pbio.2005206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Hinard V, Mikhail C, Pradervand S, Curie T, Houtkooper RH, Auwerx J, Franken P, Tafti M. Key electrophysiological, molecular, and metabolic signatures of sleep and wakefulness revealed in primary cortical cultures. The Journal of Neuroscience. 2012;32:12506–12517. doi: 10.1523/JNEUROSCI.2306-12.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Hobson JA. Sleep is of the brain, by the brain and for the brain. Nature. 2005;437:1254–1256. doi: 10.1038/nature04283. [DOI] [PubMed] [Google Scholar]
  40. Hughes ME, Hogenesch JB, Kornacker K. JTK_CYCLE: an efficient nonparametric algorithm for detecting rhythmic components in genome-scale data sets. Journal of Biological Rhythms. 2010;25:372–380. doi: 10.1177/0748730410379711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Ishimoto H, Kitamoto T. The steroid molting hormone ecdysone regulates sleep in adult Drosophila melanogaster. Genetics. 2010;185:269–281. doi: 10.1534/genetics.110.114587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Ishimoto H, Kitamoto T. Beyond molting -- roles of the steroid molting hormone ecdysone in regulation of memory and sleep in adult Drosophila. Fly. 2011;5:215–220. doi: 10.4161/fly.5.3.15477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Kamoshida Y, Fujiyama-Nakamura S, Kimura S, Suzuki E, Lim J, Shiozaki-Sato Y, Kato S, Takeyama K-I. Ecdysone receptor (EcR) suppresses lipid accumulation in the Drosophila fat body via transcription control. Biochemical and Biophysical Research Communications. 2012;421:203–207. doi: 10.1016/j.bbrc.2012.03.135. [DOI] [PubMed] [Google Scholar]
  44. Kannangara JR, Mirth CK, Warr CG. Regulation of ecdysone production in Drosophila by neuropeptides and peptide hormones. Open Biology. 2021;11:200373. doi: 10.1098/rsob.200373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Keene AC, Duboué ER, McDonald DM, Dus M, Suh GSB, Waddell S, Blau J. Clock and cycle limit starvation-induced sleep loss in Drosophila. Current Biology. 2010;20:1209–1215. doi: 10.1016/j.cub.2010.05.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Kim TW, Jeong JH, Hong SC. The impact of sleep and circadian disturbance on hormones and metabolism. International Journal of Endocrinology. 2015;2015:591729. doi: 10.1155/2015/591729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. King-Jones K, Thummel CS. Nuclear receptors -- a perspective from Drosophila. Nature Reviews. Genetics. 2005;6:311–323. doi: 10.1038/nrg1581. [DOI] [PubMed] [Google Scholar]
  48. Kininis M, Kraus WL. A global view of transcriptional regulation by nuclear receptors: gene expression, factor localization, and DNA sequence analysis. Nuclear Receptor Signaling. 2008;6:e005. doi: 10.1621/nrs.06005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Kis V, Barti B, Lippai M, Sass M. Specialized cortex glial cells accumulate lipid droplets in Drosophila melanogaster. PLOS ONE. 2015;10:e0131250. doi: 10.1371/journal.pone.0131250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Kumar S, Chen D, Jang C, Nall A, Zheng X, Sehgal A. An ecdysone-responsive nuclear receptor regulates circadian rhythms in Drosophila. Nature Communications. 2014;5:5697. doi: 10.1038/ncomms6697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Lee T, Marticke S, Sung C, Robinow S, Luo L. Cell-Autonomous requirement of the USP/ecr-B ecdysone receptor for mushroom body neuronal remodeling in Drosophila. Neuron. 2000;28:807–818. doi: 10.1016/s0896-6273(00)00155-0. [DOI] [PubMed] [Google Scholar]
  52. Leinwand SG, Scott K. Juvenile hormone drives the maturation of spontaneous mushroom body neural activity and learned behavior. Neuron. 2021;109:1836–1847. doi: 10.1016/J.NEURON.2021.04.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Li H, Janssens J, De Waegeneer M, Kolluru SS, Davie K, Gardeux V, Saelens W, David FPA, Brbić M, Spanier K, Leskovec J, McLaughlin CN, Xie Q, Jones RC, Brueckner K, Shim J, Tattikota SG, Schnorrer F, Rust K, Nystul TG, Carvalho-Santos Z, Ribeiro C, Pal S, Mahadevaraju S, Przytycka TM, Allen AM, Goodwin SF, Berry CW, Fuller MT, White-Cooper H, Matunis EL, DiNardo S, Galenza A, O’Brien LE, Dow JAT, Jasper H, Oliver B, Perrimon N, Deplancke B, Quake SR, Luo L, Aerts S, Agarwal D, Ahmed-Braimah Y, Arbeitman M, Ariss MM, Augsburger J, Ayush K, Baker CC, Banisch T, Birker K, Bodmer R, Bolival B, Brantley SE, Brill JA, Brown NC, Buehner NA, Cai XT, Cardoso-Figueiredo R, Casares F, Chang A, Clandinin TR, Crasta S, Desplan C, Detweiler AM, Dhakan DB, Donà E, Engert S, Floc’hlay S, George N, González-Segarra AJ, Groves AK, Gumbin S, Guo Y, Harris DE, Heifetz Y, Holtz SL, Horns F, Hudry B, Hung R-J, Jan YN, Jaszczak JS, Jefferis GSXE, Karkanias J, Karr TL, Katheder NS, Kezos J, Kim AA, Kim SK, Kockel L, Konstantinides N, Kornberg TB, Krause HM, Labott AT, Laturney M, Lehmann R, Leinwand S, Li J, Li JSS, Li K, Li K, Li L, Li T, Litovchenko M, Liu H-H, Liu Y, Lu T-C, Manning J, Mase A, Matera-Vatnick M, Matias NR, McDonough-Goldstein CE, McGeever A, McLachlan AD, Moreno-Roman P, Neff N, Neville M, Ngo S, Nielsen T, O’Brien CE, Osumi-Sutherland D, Özel MN, Papatheodorou I, Petkovic M, Pilgrim C, Pisco AO, Reisenman C, Sanders EN, Dos Santos G, Scott K, Sherlekar A, Shiu P, Sims D, Sit RV, Slaidina M, Smith HE, Sterne G, Su Y-H, Sutton D, Tamayo M, Tan M, Tastekin I, Treiber C, Vacek D, Vogler G, Waddell S, Wang W, Wilson RI, Wolfner MF, Wong Y-CE, Xie A, Xu J, Yamamoto S, Yan J, Yao Z, Yoda K, Zhu R, Zinzen RP, FCA Consortium§ Fly cell atlas: A single-nucleus transcriptomic atlas of the adult fruit fly. Science. 2022;375:eabk2432. doi: 10.1126/science.abk2432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Lin S, Huang Y, Lee T. Nuclear receptor unfulfilled regulates axonal guidance and cell identity of Drosophila mushroom body neurons. PLOS ONE. 2009;4:e8392. doi: 10.1371/journal.pone.0008392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. McGuire SE, Le PT, Osborn AJ, Matsumoto K, Davis RL. Spatiotemporal rescue of memory dysfunction in Drosophila. Science. 2003;302:1765–1768. doi: 10.1126/science.1089035. [DOI] [PubMed] [Google Scholar]
  56. McGuire SE, Mao Z, Davis RL. Spatiotemporal gene expression targeting with the target and gene-switch systems in Drosophila. Science’s STKE. 2004;1:l6. doi: 10.1126/stke.2202004pl6. [DOI] [PubMed] [Google Scholar]
  57. Mong JA, Baker FC, Mahoney MM, Paul KN, Schwartz MD, Semba K, Silver R. Sleep, rhythms, and the endocrine brain: influence of sex and gonadal hormones. The Journal of Neuroscience. 2011;31:16107–16116. doi: 10.1523/JNEUROSCI.4175-11.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Morgan D, Tsai SC. Sleep and the endocrine system. Critical Care Clinics. 2015;31:403–418. doi: 10.1016/j.ccc.2015.03.004. [DOI] [PubMed] [Google Scholar]
  59. Ng FS, Tangredi MM, Jackson FR. Glial cells physiologically modulate clock neurons and circadian behavior in a calcium-dependent manner. Current Biology. 2011;21:625–634. doi: 10.1016/j.cub.2011.03.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Nicholson L, Singh GK, Osterwalder T, Roman GW, Davis RL, Keshishian H. Spatial and temporal control of gene expression in Drosophila using the inducible GeneSwitch GAL4 system. I. screen for larval nervous system drivers. Genetics. 2008;178:215–234. doi: 10.1534/genetics.107.081968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Okamoto N, Viswanatha R, Bittar R, Li Z, Haga-Yamanaka S, Perrimon N, Yamanaka N. A membrane transporter is required for steroid hormone uptake in Drosophila. Developmental Cell. 2018;47:294–305. doi: 10.1016/j.devcel.2018.09.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Oostra V, Mateus ARA, van der Burg KRL, Piessens T, van Eijk M, Brakefield PM, Beldade P, Zwaan BJ. Ecdysteroid hormones link the juvenile environment to alternative adult life histories in a seasonal insect. The American Naturalist. 2014;184:E79–E92. doi: 10.1086/677260. [DOI] [PubMed] [Google Scholar]
  63. Regalado JM, Cortez MB, Grubbs J, Link JA, van der Linden A, Zhang Y. Increased food intake after starvation enhances sleep in Drosophila melanogaster. Journal of Genetics and Genomics = Yi Chuan Xue Bao. 2017;44:319–326. doi: 10.1016/j.jgg.2017.05.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Roller J. Endocrine system and its functions. Archives of Clinical and Experimental Surgery. 2021;10:1 [Google Scholar]
  65. Schwedes CC, Carney GE. Ecdysone signaling in adult Drosophila melanogaster. Journal of Insect Physiology. 2012;58:293–302. doi: 10.1016/j.jinsphys.2012.01.013. [DOI] [PubMed] [Google Scholar]
  66. Seidner G, Robinson JE, Wu M, Worden K, Masek P, Roberts SW, Keene AC, Joiner WJ. Identification of neurons with a privileged role in sleep homeostasis in Drosophila melanogaster. Current Biology. 2015;25:2928–2938. doi: 10.1016/j.cub.2015.10.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Shaw PJ, Cirelli C, Greenspan RJ, Tononi G. Correlates of sleep and waking in Drosophila melanogaster. Science. 2000;287:1834–1837. doi: 10.1126/science.287.5459.1834. [DOI] [PubMed] [Google Scholar]
  68. Sieber MH, Spradling AC. Steroid signaling establishes a female metabolic state and regulates SREBP to control oocyte lipid accumulation. Current Biology. 2015;25:993–1004. doi: 10.1016/j.cub.2015.02.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Singh P, Donlea JM. Bidirectional regulation of sleep and synapse pruning after neural injury. Current Biology. 2020;30:1063–1076. doi: 10.1016/j.cub.2019.12.065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Stahl BA, Peco E, Davla S, Murakami K, Caicedo Moreno NA, Meyel DJ, Keene AC. The taurine transporter eaat2 functions in ensheathing glia to modulate sleep and metabolic rate. Curr Biol. 2018;28:3700–3708. doi: 10.1016/J.CUB.2018.10.039. [DOI] [PubMed] [Google Scholar]
  71. Stanhope BA, Jaggard JB, Gratton M, Brown EB, Keene AC. Sleep regulates glial plasticity and expression of the engulfment receptor draper following neural injury. Current Biology. 2020;30:1092–1101. doi: 10.1016/j.cub.2020.02.057. [DOI] [PubMed] [Google Scholar]
  72. Terán-Pérez G, Arana-Lechuga Y, Esqueda-León E, Santana-Miranda R, Rojas-Zamorano JÁ, Velázquez Moctezuma J. Steroid hormones and sleep regulation. Mini Reviews in Medicinal Chemistry. 2012;12:1040–1048. doi: 10.2174/138955712802762167. [DOI] [PubMed] [Google Scholar]
  73. Terashima J, Takaki K, Sakurai S, Bownes M. Nutritional status affects 20-hydroxyecdysone concentration and progression of oogenesis in Drosophila melanogaster. The Journal of Endocrinology. 2005;187:69–79. doi: 10.1677/joe.1.06220. [DOI] [PubMed] [Google Scholar]
  74. Thimgan MS, Suzuki Y, Seugnet L, Gottschalk L, Shaw PJ. The perilipin homologue, lipid storage droplet 2, regulates sleep homeostasis and prevents learning impairments following sleep loss. PLOS Biology. 2010;8:466. doi: 10.1371/journal.pbio.1000466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Toda H, Williams JA, Gulledge M. A sleep-inducing gene, nemuri, links sleep and immune function in Drosophila. Science. 2019;515:509–515. doi: 10.1126/science.aat1650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Uyehara CM, McKay DJ. Direct and widespread role for the nuclear receptor ecr in mediating the response to ecdysone in Drosophila. PNAS. 2019;116:9893–9902. doi: 10.1073/pnas.1900343116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Vafopoulou X, Steel CGH. Cytoplasmic travels of the ecdysteroid receptor in target cells: pathways for both genomic and non-genomic actions. Frontiers in Endocrinology. 2012;3:43. doi: 10.3389/fendo.2012.00043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Wang G, Yang LL, Liu HY. Glial cells missing gene upregulated by ecdysone in Drosophila. Applied Mechanics and Materials. 2014;618:273–277. doi: 10.4028/www.scientific.net/AMM.618.273. [DOI] [Google Scholar]
  79. Weljie AM, Meerlo P, Goel N, Sengupta A, Kayser MS, Abel T, Birnbaum MJ, Dinges DF, Sehgal A. Oxalic acid and diacylglycerol 36:3 are cross-species markers of sleep debt. PNAS. 2015;112:2569–2574. doi: 10.1073/pnas.1417432112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Williams JA. Sleep, immunity, and stress: novel insights from Drosophila. Handb Behav Neurosci. 2019;30:349–362. doi: 10.1016/B978-0-12-813743-7.00023-2. [DOI] [Google Scholar]
  81. Wu B, Ma L, Zhang E, Du J, Liu S, Price J, Li S, Zhao Z. Sexual dimorphism of sleep regulated by juvenile hormone signaling in Drosophila. PLOS Genetics. 2018;14:e1007318. doi: 10.1371/journal.pgen.1007318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Xu T, Jiang X, Denton D, Kumar S. Ecdysone controlled cell and tissue deletion. Cell Death and Differentiation. 2020;27:1–14. doi: 10.1038/s41418-019-0456-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Yamanaka N, Rewitz KF, O’Connor MB. Ecdysone control of developmental transitions: lessons from Drosophila research. Annual Review of Entomology. 2013;58:497–516. doi: 10.1146/annurev-ento-120811-153608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Yang X, Lamia KA, Evans RM. Nuclear receptors, metabolism, and the circadian clock. Cold Spring Harbor Symposia on Quantitative Biology. 2007;72:387–394. doi: 10.1101/sqb.2007.72.058. [DOI] [PubMed] [Google Scholar]
  85. Yildirim K, Petri J, Kottmeier R, Klämbt C. Drosophila glia: few cell types and many conserved functions. Glia. 2019;67:5–26. doi: 10.1002/glia.23459. [DOI] [PubMed] [Google Scholar]
  86. Yu F, Schuldiner O. Axon and dendrite pruning in Drosophila. Current Opinion in Neurobiology. 2014;27:192–198. doi: 10.1016/j.conb.2014.04.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Zhang J, Zhang B, Zhang Y. Cancer immunology and cancer immunodiagnosis 2016. Journal of Immunology Research. 2017;2017:9127382. doi: 10.1155/2017/9127382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Zhang SL, Yue Z, Arnold DM, Artiushin G, Sehgal A. A circadian clock in the blood-brain barrier regulates xenobiotic efflux. Cell. 2018;173:130–139. doi: 10.1016/j.cell.2018.02.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Zubeldia-Brenner L, Roselli CE, Recabarren SE, Gonzalez Deniselle MC, Lara HE. Developmental and functional effects of steroid hormones on the neuroendocrine axis and spinal cord. Journal of Neuroendocrinology. 2016;28:e1. doi: 10.1111/jne.12401. [DOI] [PMC free article] [PubMed] [Google Scholar]

Editor's evaluation

Mani Ramaswami 1

This is a strong manuscript that identified a role for ecdysone signaling and cortex glia in sleep regulation. The manuscript is important because it opens up new avenues of study for examining how hormone signaling and glia regulate sleep and circadian rhythms.

Decision letter

Editor: Mani Ramaswami1
Reviewed by: Alex C Keene2

Our editorial process produces two outputs: (i) public reviews designed to be posted alongside the preprint for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.

Decision letter after peer review:

Thank you for submitting your article "Ecdysone acts through cortex glia to regulate sleep in Drosophila" for consideration by eLife. Your article has been reviewed by 2 peer reviewers, and the evaluation has been overseen by Mani Ramaswami as Reviewing Editor and K VijayRaghavan as the Senior Editor. The following individual involved in the review of your submission has agreed to reveal their identity: Alex C Keene (Reviewer #1).

The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.

Essential revisions:

1) Please provide the necessary details requested regarding background controls and how they may influence conclusions reached. The specific issues pertaining to the RepoGS driver be addressed better by additional experiments using repo-GAL4 combined with GAL80ts, which would provide independent confirmation of the conclusions reached, which would be useful given concerns with the background strains.

2) The effect of Ecdysone perturbations should be shown separately for starved flies and fed flies for reasons explained in Reviewer 2's comment 2.

3) Please make necessary clarifications in the Methods section pertaining to point 2 above.

4) There is. concern that evidence for "mobilization of lipid droplets being the mechanism linking steroid signaling to sleep" is currently quite weak. Additional experiments to strengthen this connection would be valuable, but if these cannot be done, then please qualify the conclusions and modify the discussion to acknowledge the remaining ambiguities in the mechanism by which ecdysone affects sleep.

Reviewer #1 (Recommendations for the authors):

I have described a number of concerns, primarily related to interpretations.

1. For the targeted screen in Figure 1, it is surprising that almost all of the genes result in reduced sleep. Is there concern that this may result from background differences? If not, it would seem to deserve additional commentary that all NHRs impact sleep in both neurons and glia.

2. Again, for Figure 1, I very much appreciate the data presentation because it allows all data to be depicted on simple graphs. I do think it would be beneficial to include a Supplemental Figure depicting data with the mean and variance (rather than the differences compared to controls).

3. Line 136: The statement 'perhaps because EcI is one of the most highly expressed genes in glia and may be insufficiently knocked down by RNAi' is very speculative. Suggest directly testing this, or removing the statement. It could also be moved to the discussion.

4. Line 146 states EcR functions specifically in glia to regulate circadian rhythms, but the data also suggest a role in neurons. Suggest changing to 'is required in glia.'

5. Why is the number of arrhythmic flies so high in the repo-GS control?

6. Suggest changing 2I to %, rather than N to allow direct comparisons between groups.

7. I cannot see the blue and green experimental data points in figures 3B and 3C.

8. Is the conclusion from 3E that ecdysone is specifically involved in sleep during starvation, or that glial ecdysone promotes sleep, and the observed sleep loss is cumulative but separate from starvation?

9. Is it possible to change the contract of Figure 5A?

10. Line 282: Since EcR has an effect on neurons, I have some concerns about the interpretations that 'ecdysone affects sleep in LDs …especially in cortex glia'.

eLife. 2023 Jan 31;12:e81723. doi: 10.7554/eLife.81723.sa2

Author response


Essential revisions:

1) Please provide the necessary details requested regarding background controls and how they may influence conclusions reached. The specific issues pertaining to the RepoGS driver be addressed better by additional experiments using repo-GAL4 combined with GAL80ts, which would provide independent confirmation of the conclusions reached, which would be useful given concerns with the background strains.

We conducted the Repo-Gal4; TubGal80ts>EcR RNAi #1 experiment, as suggested, and the results show that Repo-Gal4; TubGal80ts>EcR RNAi #1 flies sleep a similar amount at permissive temperature (18 degrees) as control flies, but their sleep is significantly less at restricted temperature (31 degrees), confirming that EcR acts in adult glia to regulate daily sleep (Figure 2 —figure supplement 3A, B). Since EcR RNAi #1 and #2 are two independent P-element transgenic lines but were generated using the same construct, we also tested three other EcR RNAi lines with Repo-GS, all of which produced reduced sleep phenotypes, further confirming that EcR RNAi knockdown in glial cells reduces sleep (Figure 2 —figure supplement 3C-E).

We did observe some differences in sleep in GS control flies from experiment to experiment, and this was a concern for us; we agree that Repo-GS flies, and perhaps all GS lines, have higher inter-individual variability. But we do not believe this affects our conclusions for the following reasons. First, we present a lot of data documenting sleep effects of EcR knockdown with Repo-GS. From our initial screening results alone, we had 144 Repo-GS control flies with an average sleep time of 728.9 minutes and an SEM of 13.37. We had 124 nsyb-GS control flies with an average of 751.4 min and SEM 14.50. For UAS-EcR RNAi #1 control flies, we had 80 flies with an average of 910.8 min and an SEM of 11.62. Since Repo-GS>EcR RNAi #1 flies had an average sleep time of 460 minutes, despite greater variability in Repo-GS control flies, glial EcR knockdown significantly reduced sleep compared to both control groups. Second, while Repo-GS flies showed greater variance in daytime sleep, their nighttime sleep was more consistent (daytime and nighttime SEM 9.297 vs. 6.404), so we also showed nighttime sleep for our screen, and we chose EcR as a candidate gene based on total sleep and nighttime sleep. Third, while Repo-GS control flies shown in the EcI RNAi experiment slept significantly less than Repo-GS from the initial screen, likely due to experimental variability, the average of 620 minutes was still much larger than the average of Repo-GS>EcR RNAi #1 in the initial screen. Last, data from our new TARGET system and three other EcR RNAis confirm that glial EcR modulates sleep. Overall, despite the small differences in control groups, our experimental groups are always significant compared with the two control groups in each replicate, and we reconfirmed these results by using different systems and different RNAi lines.

2) The effect of Ecdysone perturbations should be shown separately for starved flies and fed flies for reasons explained in Reviewer 2's comment 2.

We have done so. As shown by Hiroshi Ishimoto et al. (2010), we find that 20E promotes sleep in (fed) wild-type flies (Figure 3A, E); and we show that it also does so in starved flies (Figure 3B, E). Thus, ecdysone can promote sleep in both fed and starved flies, and it likely does so independently of starvation.

3) Please make necessary clarifications in the Methods section pertaining to point 2 above.

Methods section has been updated in accordance with reviewers’ requests.

4) There is. concern that evidence for "mobilization of lipid droplets being the mechanism linking steroid signaling to sleep" is currently quite weak. Additional experiments to strengthen this connection would be valuable, but if these cannot be done, then please qualify the conclusions and modify the discussion to acknowledge the remaining ambiguities in the mechanism by which ecdysone affects sleep.

We are happy to report that we conducted additional experiments to strengthen the link between ecdysone and lipid droplets and these support our conclusion. We speculated that since ecdysone feeding mobilizes lipid droplets, glial EcR knockdown should cause flies to accumulate more lipids. Therefore, we performed lipid staining comparing vehicle control and RU486-induced groups of Repo-GS>EcR RNAi flies (new figure 6 —figure supplement 1). We found that induction of EcR knockdown in glial cells with RU resulted in more LDs, whereas RU had no effect on UAS control flies, suggesting that ecdysone signaling bidirectionally affects LDs in glial cells. Increased sleep with ecdysone feeding reduces LDs while reduced sleep with loss of ecdysone signaling increases LDs.

In response to the reviewer’s comment that lsd2 mutants (which are compromised in LD formation) may not respond to ecdysone because they are incapable of increasing sleep, we fed lsd-2 mutant flies with gaboxadol, a GABA agonist known to induce deep sleep. Gaboxadol treatment significantly increased the amount of sleep in lsd-2 mutants (new Figure 6 —figure supplement 2), indicating that lsd-2 mutant flies can sleep more. Lack of a sleep-promoting effect of ecdysone on lsd-2 mutants, together with bidirectional effects of ecdysone on LDs, indicate strongly that ecdysone regulates sleep through lipid droplets in glial cells.

Reviewer #1 (Recommendations for the authors):

I have described a number of concerns, primarily related to interpretations.

1. For the targeted screen in Figure 1, it is surprising that almost all of the genes result in reduced sleep. Is there concern that this may result from background differences? If not, it would seem to deserve additional commentary that all NHRs impact sleep in both neurons and glia.

From Figure 1 and the updated Figure1 – source data 1, it is clear that almost all NHR knockdowns result in varying degrees of sleep reduction. So yes, we agree that most NHRs affect sleep both in neurons and glia. Half of all NHRs respond to ecdysone, so it is not surprising that these ecdysone responsive NHRs interfere with sleep, but why all the other NHRs play a role in sleep deserves further exploration. Since each NHR knockdown line was compared to both its GS control and UAS control, this is unlikely to be a background issue. We discussed this result in the manuscript as suggested.

Surprisingly, we found that knockdown of most NHRs in neurons and glial cells reduced adult sleep to varying levels compared to their GS and UAS controls, suggesting that the endocrine system in general plays a positive role in sleep regulation.”

2. Again, for Figure 1, I very much appreciate the data presentation because it allows all data to be depicted on simple graphs. I do think it would be beneficial to include a Supplemental Figure depicting data with the mean and variance (rather than the differences compared to controls).

We have updated Figure1- source data 1 with mean total/day/night sleep amount and variance for each genotype.

3. Line 136: The statement 'perhaps because EcI is one of the most highly expressed genes in glia and may be insufficiently knocked down by RNAi' is very speculative. Suggest directly testing this, or removing the statement. It could also be moved to the discussion.

We have removed the statement. Based on the transcriptome data from DeSalvo et al., 2014, EcI is among the top 50 most enriched surface glia genes and is expressed at 21-fold higher levels in surface glia than in whole brain, but yes, the original statement was speculative. Thanks for the suggestion.

4. Line 146 states EcR functions specifically in glia to regulate circadian rhythms, but the data also suggest a role in neurons. Suggest changing to 'is required in glia.'

Thanks for the suggestion; we have changed the sentence as suggested.

5. Why is the number of arrhythmic flies so high in the repo-GS control?

In the original Figure 2I, about 34% of Repo-GS flies were arrhythmic compared to 21% of nsyb-GS flies, and 13% of EcR RNAi #1 flies. We believe the data were affected by one particular repeat of this experiment (as the repeats were pooled in the original figure), and so we compared multiple repeats across genotypes. The new Figure 2I shows that the percentage of rhythmicity is not significantly different between Repo-GS control flies, nsyb-GS control flies and EcR RNAi #1 flies. Importantly, despite the variability in the circadian rhythms of Repo-GS flies (as in their sleep behavior), they are still robustly different from experimental (Repo-GS>EcR RNAi) no matter which way the data are analyzed.

6. Suggest changing 2I to %, rather than N to allow direct comparisons between groups.

Figure2I was updated and please see explanation above.

7. I cannot see the blue and green experimental data points in figures 3B and 3C.

Sorry for the confusion. For Figure 3C and 3D, there are only two groups, fed and starved, of nSyb-/Repo-GS>EcR RNAi #1 flies; in the original version the black curve was the fed group, and the red curve was the starved group. In the updated manuscript, we changed the colors in Figure 3C and 3D, hopefully this time it is clear.

8. Is the conclusion from 3E that ecdysone is specifically involved in sleep during starvation, or that glial ecdysone promotes sleep, and the observed sleep loss is cumulative but separate from starvation?

We believe the effect of ecdysone on sleep is independent of starvation, but the role of glia in effects of ecdysone is especially evident during starvation (Figure 3E).

9. Is it possible to change the contract of Figure 5A?

Yes, we changed the light grey color in Figure 5 to a darker grey.

10. Line 282: Since EcR has an effect on neurons, I have some concerns about the interpretations that 'ecdysone affects sleep in LDs …especially in cortex glia'.

That’s a good point, and we have rephrased the sentence as “Ecdysone affects sleep in large part by modulating LDs accumulated in glial cells, especially cortex glia.’

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Figure 1—source data 1. Detailed sleep phenotypes of nuclear hormone receptor (NHR) RNAi screening lines.
    Figure 2—source data 1. Sleep and circadian phenotypes resulting from pan-neuronal or pan-glial knockdown of ecdysone receptor (EcR).
    Figure 2—source data 2. Sleep phenotypes resulting from pan-neuronal or pan-glial knockdown of E75.
    Figure 2—source data 3. Sleep phenotypes resulting from pan-neuronal or pan-glial knockdown of Hr51 and sleep phenotypes of adult-specific neuronal and glial knockdown of ecdysone receptor (EcR).
    Figure 2—source data 4. Sleep phenotypes resulting from pan-glial knockdown of ecdysone receptor (EcR) by temporal and regional gene expression targeting (TARGET) system and different EcR RNAi lines.
    Figure 2—source data 5. Sleep phenotypes resulting from pan-neuronal or pan-glial knockdown of EcI and overexpression of ecdysone receptor (EcR) common isoforms.
    Figure 3—source data 1. Sleep phenotypes of starvation on wild-types and ecdysone receptor (EcR) disrupted flies.
    Figure 3—source data 2. Sleep phenotypes of ecdysone treatment and heat shock when ecdysone receptor (EcR) was disrupted in neurons and glial cells.
    Figure 3—source data 3. Ecdysone levels in both fly brain and periphery, and the expression levels of ecdysone responsive genes.
    Figure 4—source data 1. Quantification of Anti-EcR staining in the cortex glia layer.
    Figure 5—source data 1. Sleep phenotypes resulting from subglial knockdown of ecdysone receptor (EcR).
    Figure 5—source data 2. Sleep phenotypes of adult-specific ecdysone receptor (EcR) disruption in different subglial populations.
    Figure 6—source data 1. The effects of ecdysone on lipid droplets and sleep.
    Figure 6—source data 2. Lipid droplets changes resulting from glial ecdysone receptor (EcR) knockdown.
    Figure 6—source data 3. Sleep phenotypes of gaboxadol treatment in lsd-2 mutant flies.
    MDAR checklist

    Data Availability Statement

    All data analyzed and reported in this study are included in the manuscript, supplementary tables, and source data linked to figures.


    Articles from eLife are provided here courtesy of eLife Sciences Publications, Ltd

    RESOURCES